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 ABSTRACT OF DISSERTATION 
 
 
 
 
 THE ROLE OF DIAPHRAGMATIC BREATHING  
IN SELF-REGULATION SKILLS TRAINING 
 
 
A central component of many psychological interventions is breathing training. Breathing 
training protocols based on a mindfulness or a cognitive behavioral therapy (CBT) have 
demonstrated value in the management of psychological and medical ailments. Yet, despite the 
wealth of literature examining each approach, little direct comparison exists. An additional 
concern is the proliferation of smart phone health (mHealth) applications (apps) providing 
breathing training with little empirical evidence to support their clinical use. A possible 
explanation for the interest in breathing and mHealth apps is the growing body of literature 
indicating breathing training provides wide ranging health benefits through improved stasis of the 
autonomic nervous system (ANS). As ANS dysregulation underlies many chronic health 
conditions such as persistent temporomandibular disorders (TMDs), there is a need for empirical 
research to identify the most effective modality of breathing training and validate the clinical 
efficacy of breathing based mHealth apps.  
 
Study One compared the effectiveness of a mindfulness breathing meditation (MB) and a 
CBT based protocol teaching diaphragmatic breathing (DB) to improve biomarkers of ANS 
stasis. An attention control approach based on the Nolen-Hoeksema task (C) was included as a 
comparison group. Ninety participants were randomly assigned to either the MB, DB, or C 
condition. Within each condition, 30 participants were provided skills training with practice time 
and completed a behavioral self-regulation task. Participants in the DB condition approach had 
significantly lower breathing rates than those in the MB and C conditions (p < .001). DB 
condition participants experienced improvements on high-frequency heart rate variability (p < 
.05) and the standard deviation in NN intervals (p < .001), which served as indicators for ANS 
stasis. No differences were found between conditions on the behavioral self-regulation task (p’s > 
.05). Given these results, the DB training protocol was converted into a mHealth app to facilitate 
a clinical trial with patients suffering persistent TMDs.  
 
Study Two examined the additive benefits of including the mHealth app with standard 
dental care (SDC+) versus standard dental care alone (SDC). Nineteen patients seeking care for 
persistent TMDs were recruited. All participants were asked to track daily ratings of pain (VAS), 
relaxation (RR), and complete weekly assessments on several comorbid psycho-social factors. 
Within the SDC+ condition participants were asked to track the proximate effects of 
each breathing practice on VAS and RR ratings. Given a high drop-out rate (nine participants) 
and low overall sample size (N = 10), results are exploratory at best. Within the SDC+ condition, 
results indicated reliable improvements in average VAS and RR ratings from before and after 
SDC+ participants used the mHealth app (p’s < .05). 
 
Within a one session training paradigm, results supported the use of a DB based 
intervention above the use of a MB or C intervention. Future research should consider the effects 
of having multiple training sessions. Study Two results were complicated by a limited sample 
size and failed to provide a clear picture of whether the conjunctive treatment in the SDC+ 
condition provided additional symptom relief above traditional dental care alone. Although 
exploratory results indicated the mHealth app provided temporary improvements in pain and 
feelings of relaxation, a well powered trial is needed to clarify whether the finding represents an 
enduring treatment effect.  
 
KEYWORDS: Temporomandibular disorders, myalgia, chronic pain, diaphragmatic breathing, 
smart phone 
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Chapter One: Introduction 
Temporomandibular disorders (TMDs) have a prevalence rate of 10-15% and represent a 
debilitating chronic pain condition (Roldán-Barraza, Janko, Villanueva, Araya, & Lauer, 2014). 
Chronic pain occurs when pain persists past the expected tissue healing time of three months and 
is described as an unpleasant sensory and emotional experience without apparent biological value 
(Harstall & Ospina, 2003; Flor & Turk, 2015). TMDs are one of the most common chronic 
orofacial pain conditions and represent a heterogeneous family of musculoskeletal disorders. The 
average pain intensity of TMDs is comparable to back pain and TMDs often progress into chronic 
pain conditions (referred to as persistent TMDs from here forward) in 51% to 67% of diagnosed 
cases (Maixner et al., 2011b). In addition, research has suggested individuals with persistent 
TMDs endure compromised psychological functioning (Burris, Evans, & Carlson, 2010; Carlson, 
2007; Carlson et al., 1998; Fillingim et al., 2013; Gatchel, Peng, Peters, Fuchs, & Turk, 2007). 
Although the relationship between pain and psychological functioning is complex and 
bidirectional, studies indicate individuals with persistent TMDs experience higher base rates for 
mood and anxiety disorders compared to pain free individuals (Carlson, 2007; Fillingim et al., 
2013; Fillingim et al., 2011; Edwards, Dwarkin, Sullivan, Turk, & Wasan, 2016). Persistent 
TMDs are also linked with chronic activation of the sympathetic nervous system, which leads to 
unnecessary allostatic load on the body and subsequent increased susceptibility to other persistent 
pain conditions (Goldstein & McEwen, 2002; Kendall-Tackett, 2010; Maixner et al., 2011a; 
McEwen, 2006; Purdy, 2013; Sapolsky, 2004). Despite the complex nature of persistent TMDs, 
interventions can significantly improve symptoms and enable individuals to live high quality lives 
(Carlson, Bertrand, Ehrlich, Maxwell, & Burton, 2001; Schmidt, Joyner, Carlson, & Hooten, 
2013; Roldán-Barraza et al., 2014; Turner, Mancl, & Aaron, 2006). 
Traditional Dental Treatment  
Currently, there are a variety of dental interventions for TMDs. Most dental providers 
start with the most conservative and least invasive interventions. If required, interventions shift to 
2 
 
more invasive and irreversible approaches such as surgery or orthodontics (De Boever, Nilner, 
Orthlieb, & Steenks, 2008; Okeson, 2014). The first treatment approach is often patient education 
including clenching awareness, habit reversal, soft diet, gentle stretches, sleep hygiene, and 
functioning within pain free limits. If unsuccessful, more intensive treatments are offered based 
on each patient’s symptom presentation and include the use of more advanced self-regulation 
skills training, non-steroidal anti-inflammatory medications (e.g. Ibuprofen, Meloxicam), 
stabilization splint therapy, muscle relaxant medications (e.g. Baclofen, Tizanidine), injections 
(e.g. Botox), and finally irreversible dental interventions (i.e. surgery, orthodontics, or occlusal 
adjustments). Despite an arsenal of treatments, patients with persistent TMDs find symptom 
management is the normative experience rather than symptom resolution.  
Symptom management for persistent TMDs consumes considerable patient and clinic 
resources (Carlson, 2007). Research has indicated a small subset of patients with persistent TMDs 
account for an estimated 85% of the total costs associated with treating all diagnosed cases of 
persistent TMDs (Maixner et al., 2011b). Therefore, research identifying risk factors for the 
development and maintenance of persistent TMDs is essential. Maixner et al. (2011b) advocated 
a heuristic model of causal influences for the onset and persistence of TMDs. The model 
identified psychological distress and pain amplification as two overarching phenotypical risk 
factors that include a constellation of more specific phenotypical risk factors. Given the complex 
interactions among the two-overarching phenotypical risk factors, efficacious treatment is best 
achieved through a biopsychosocial framework (Schiffman et al., 2014; Gatchel et al., 2007). The 
biopsychosocial model of treatment emphasizes that the transition from pain to chronic pain 
warrants a shift in treatment perspective from disease (pain alone) to illness (pain plus 
contributing psychosocial factors) (Gatchel et al., 2007). The importance of including 
psychosocial treatments into traditional medical approaches has received increasing interest. 
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Psychosocial Treatment 
In 2014, a meta-analysis of available randomized clinical trials examined the 
effectiveness of psychosocial and dental treatments in amelioration of persistent TMD 
symptomology (Roldán-Barraza et al., 2014). Although interpretations of data were hampered by 
a limited number of studies containing standardized measures, results suggested participants 
experienced greater long-term relief from self-reported pain and depression symptoms following 
a psychosocial intervention compared to standard dental treatment alone. In 2010, Davis et al., 
found stress management, psychological distress, sleep problems, and psychophysiological self-
regulation predicted pain symptoms better than measures of oral parafunction (i.e. problem 
behaviors associated with the muscles used for chewing). Taken together, adherence to the 
biopsychosocial model of treatment through incorporation of psychosocial interventions into 
traditional dental treatments is likely to produce the best patient outcomes.  
For a wide range of chronic pain conditions, a 2004 meta-analysis indicated a medium to 
strong effect size for mindfulness based stress reduction (MBSR) on psychological and pain 
related outcomes (Grossman, Niemann, Schmidt, & Walach, 2004; Kabat-Zinn, 1982). Through 
enhanced awareness and balanced acceptance of the experiences in the present moment and 
mental processes, MBSR or mindfulness based interventions have built a body of literature 
supporting their ability to reduce negative affect, limit somatization, and improve vitality and 
coping. The clinical effects of mindfulness based interventions generalize well to persistent 
TMDs (Chiesa & Serretti, 2011; Grossman et al., 2004; Hofmann, Sawyer, Witt, & Oh, 2010; 
Merrill & Goodman, 2016).  
Another approach is the use of Cognitive Behavioral Therapy (CBT), which is a goal 
oriented therapy focused on changing cognitions and behaviors related to chronic pain patients’ 
common difficulties. A 2006 meta-analysis demonstrated strong support for CBT’s ability to 
reduce pain interference and depressive symptoms, and to produce clinically meaningful 
improvements in almost twice as many participants than education/control approaches (Turner et 
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al., 2006). Although the approach and therapy goals differ between mindfulness and CBT, both 
offer a means to target the biopsychosocial challenges common to patients with chronic pain 
conditions through specific skills training.  
 Considerable literature supports the use of specific components of psychosocial 
interventions for chronic pain conditions such as general relaxation practices, biofeedback, or 
specific breathing protocols (Carlson et al., 2001; Gevirtz, 2013; Lehrer & Gevirtz, 2014; 
Schmidt, Joyner, Tonyan, Reid, & Hooten, 2012; Schmidt et al., 2013; Vaschillo, Vaschillo, & 
Lehrer, 2006; Merrill & Goodman, 2016). A meta-analysis in 2007 examined CBT, self-
regulation (biofeedback, relaxation, and hypnosis), behavioral therapy, and supportive counseling 
for non-cancerous chronic low back pain. Results indicated clinical improvements were 
maximized when CBT, including instruction on self-regulation skills, was used in conjunction 
with multidisciplinary treatments versus medical or psychological treatments alone (Hoffman, 
Papas, Chatkoff, & Kerns, 2007).  
Although multiple mechanisms of change were involved, two possible explanations for 
symptom reduction are improved self-efficacy for pain management and improved pain coping 
skills (Turner, Holtzmann, & Mancl, 2007; Burns, Kubilus, Bruehl, Harden, & Lofland, 2003). 
Several recent reviews of MBSR and similar mindfulness based interventions for chronic pain 
suggested improved patient pain coping and reduced somatization may be a primary mechanism 
of psychological symptom and stress reduction (Chiesa & Serretti, 2011). Yet, despite a wealth of 
material indicating the clinical utility of multidisciplinary treatment including psychosocial 
interventions, it remains unclear to what degree each intervention influences symptom reduction 
(Kress et al., 2015). Therefore, a logical next step is to examine specific components of self-
regulation interventions in conjunction with traditional medical treatments for chronic pain 
conditions like persistent TMDs. 
The use of breathing for mind-body healing has existed for many centuries and was 
codified in the 18th century with Zen Rinzai practices but has evolved and been incorporated into 
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a large array of western behavioral relaxation interventions (Lehrer, Sasaki, & Saito, 1999; 
Schmidt et al., 2013). One of the primary meditation exercises within mindfulness therapies is 
bringing present focused and non-judgmental awareness to one’s breathing, while CBT 
interventions use a more didactic approach to teach patients specific breathing interventions. 
Research has indicated breathing interventions can influence heart rate variability (HRV), which 
is a biomarker negatively correlated with persistent TMD symptom severity and an indicator of 
stasis within the autonomic nervous system (Burg, Wolf, & Michalak, 2012; Krygier et al., 2013; 
Lehrer, Vaschillo, & Vaschillo, 2000; Maixner et al., 2011a; Schmidt et al., 2013). Previous 
research has indicated chronic pain conditions like persistent TMDs result in decreased HRV and 
reduce an individual’s ability to physiologically self-regulate (Solberg Nes, Carlson, Crofford, 
Leeuw, & Segerstrom, 2010). Interestingly, research suggests regular activation of self-regulatory 
systems improves future capacity for more efficient self-regulation (Muraven, Baumeister, & 
Tice, 1999).  
Several breathing based interventions are known to improve HRV and have demonstrated 
efficacy in management of persistent TMDs or similar chronic pain conditions (Brown, Gerbarg, 
& Muench, 2013; Carlson et al., 2001; Lehrer, 2007; Schmidt et al., 2012; Schmidt et al., 2013). 
The etiology of persistent TMDs is complex and often complicated by the bi-directional 
relationship between physiological symptoms and psycho-social factors. However, evidence 
supports three possible mechanisms of action for breathing that likely overlap to improve 
management of persistent pain conditions.  
First, chronic pain conditions are consistently linked to dysregulation within the 
autonomic nervous system, quantified as decreased HRV (Maixner et al., 2011a). HRV reflects 
vagus nerve control of cardiac inter-beat intervals with increased vagus nerve influence 
represented by higher HRV (Fried & Grimaldi, 1993, p.118; Porges, 2007). HRV is also 
influenced by the baroreflex. The baroreflex modulates blood pressure through changes in heart 
rate and contraction of blood vessels in efforts to maintain a consistent blood pressure (Lehrer et 
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al., 2003; Lehrer & Gevirtz, 2014; Porges, 2007). Research indicates vagal and baroreflex control 
over HRV is optimally increased through breathing diaphragmatically at a rate of 5.5 to six 
breaths-per-minute (Lehrer et al., 2000; Lehrer & Gevirtz, 2014; Russell, Scott, Boggero, & 
Carlson, 2016). Within this range, the effects of breathing on HRV are amplified by 
compensatory fluctuations in heart rate through the baroreflex (Lehrer et al., 2003). 
Breathing training also provides relief for persistent pain conditions through reductions in 
neuronal activity. Chronic pain conditions are associated with hyper-excitability of neurons in 
sensory pathways (Rogawski & Löscher, 2004) which contribute to increased pain via a positive 
feedback loop of aberrant nociception (Nordin, Nyström, Wallin, & Hagbarth, 1984; Ochoa & 
Torebjörk, 1989). Similar to anti-epileptic drugs (e.g. gabapentin) that are hypothesized to inhibit 
neuronal hyperactivity (Yogeeswari, Ragavendran, & Sriram, 2007), paced breathing 
interventions may affect neuronal firing thresholds thereby providing pain relief (Fried & 
Grimaldi, 1993). During inhalation, sodium (Na+) ions flow into neurons as the transmembrane is 
depolarized and trigger an action potential. During exhalation, the transmembrane is polarized 
which blocks an influx of sodium ions and subsequently prevents an action potential. Therefore, 
increased respiration rates result in higher rates of sodium channel neuronal firing whereas lower 
respiration rates can limit the frequency of neuronal firings providing a reduced pain experience 
(Glynn, Lloyd, & Folkhard, 1981). Research on hyperventilation supports this mechanism of 
action (Fried, 1987; Fried & Grimaldi, 1993).  
The final mechanism of action for breathing on persistent pain conditions is related to 
blood chemistry. Research suggests lower breathing rates facilitate a balanced exchange of 
oxygen and CO2 during periods of physical inactivity, reduce neuronal firing, and support the 
bicarbonate ion buffer system (Chen, Eldridge, & Wagner, 1991; Fried & Grimaldi, 1993). The 
bicarbonate ion buffer system regulates blood pH between a range of 7.3 to 7.5 ideally (for a 
complete review of this system see Hall & Guyton, 2011). When blood becomes too acidic, the 
body experiences a range of symptoms easily relieved through increased respiration. However, 
7 
 
when the body experiences low levels of CO2 within the blood (hypocapnia and corresponding 
alkalosis) it can result in increased neuronal firing, muscle fatigue, vasocontraction, increased 
sympathetic tone, and increased pain (Fried & Grimaldi, 1993; Laffey & Kavanagh, 2002). Low 
concentrations of CO2 within the blood are also associated with increases in pH level that can 
reduce the ability of oxygen to disassociate from hemoglobin to replenish cells. Taken together, 
proper breathing likely improves pain management through multiple mechanisms. 
Breathing interventions are also linked to positive effects on neural regions associated 
with emotion regulation, cognitive function, attention, subjective awareness, and decision making 
(Brown, Gerbarg, & Muench, 2013; Carlson et al., 2001; Fried & Grimaldi, 1993 p. 87-88; 
Kaushik, Kaushik, Mahajan, & Rajesh, 2005; Mehling, Hamel, Acree, Byl, & Hecht, 2005; 
Zautra, Fasman, Davis, & Craig, 2010). Further, research has suggested proper breathing training 
may prevent hypoxic events and protect against aggravation of anxiety symptoms, depressive 
symptoms, or increased pain sensitivity (Brown, Gerbarg, & Muench, 2013; Fried & Grimaldi, 
1993 p. 88-92), which are both comorbid conditions for persistent TMDs (Greenspan et al., 
2011). Despite less evidence for a direct effect of breathing on psychological distress, the high 
comorbidity of psychological distress within patients suffering persistent TMDs warrants 
consideration of a behavioral intervention likely to affect both psychological and physical 
systems (Fillingim et al., 2013).  
Current Study 
 Given the support for breathing interventions with patients suffering persistent TMDs, the 
present project first compared the efficacy of breathing interventions modeled after mindfulness 
breathing meditations and CBT-oriented diaphragmatic breathing training protocols. Then, the 
training approach found to be most effective, was converted into a smart phone health (mHealth) 
application (app) to improve accessibility and facilitate a clinical trial with patients suffering 
persistent TMDs. Both studies explored important theoretical questions. Despite previous 
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literature suggesting both mindfulness and CBT based approaches for breathing training are 
effective at increasing HRV, little research exists directly comparing the two (Kabat-Zinn, 2005).  
Therefore, the first study tested the effects of different training approaches for breathing 
based relaxation strategies. A 3x3 between-subjects design was used to examine the effects of a 
mindfulness based breathing training, CBT based training on diaphragmatic breathing, and an 
attention control approach on HRV indices and other indicators of psychological health. For the 
second study, the training approach found to be most effective from the first study (e.g. CBT-
based diaphragmatic breathing) was used to create an mHealth app.  
With the widespread availability of smart phone devices as a platform for 
anytime/anywhere health interventions and their cost efficiency, mHealth apps are fast becoming 
a popular alternative to clinic based behavioral interventions (Luxton, Hansen, & Stanfill, 2014). 
Given the positive outcomes from breathing training, there is considerable effort on developing 
technology assisted breathing interventions (Chittaro & Sioni, 2014a, 2014b; Luxton et al., 2014; 
Mani, Kavanagh, Hides, & Stoyanov, 2015; National Center for Telehealth & Technologies, 
2011a, 2011b). The United States Department of Defense in conjunction with the Veteran’s 
Health Administration has committed substantial resources to develop several mHealth apps 
focused on diaphragmatic breathing training (National Center for Telehealth & Technologies, 
2011a, 2011b). In addition, it is noteworthy that a recent review of mindfulness based mHealth 
apps resulted in 560 unique options with 23 considered “high quality”, all of which included a 
breathing meditation (Mani et al., 2015). The second study evaluated the clinical effectiveness of 
a mHealth app within a clinical population of patients suffering from persistent TMDs. As 
persistent TMDs represent an array of disorders with a broad range of etiologies, the second study 
focused on persistent TMDs with a muscle based etiology. Participants were required to have a 
primary diagnosis of myalgia (i.e. local myalgia, myofascial pain, and myofascial pain with 
referral) based on the Research Diagnostic Criteria for TMDs (Schiffman et al., 2014). The 
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mHealth app was evaluated by examining standard dental care alone (SDC) versus standard 
dental care plus the mHealth app (SDC+).  
The second study had two main objectives. The first objective was to evaluate the 
effectiveness of the mHealth app in teaching slow paced diaphragmatic breathing. Following 
treatment, we anticipated SDC+ participants would show lower resting breathing rates than SDC 
participants. We also anticipated SDC+ participants would show increased HRV, diaphragm 
muscle engagement, and end tidal CO2 (ETCO2) measurements as compared to SDC participants. 
The second objective was to assess the intervention’s ability to improve clinical outcomes above 
standard dental interventions. We anticipated SDC+ participants would report greater reduction in 
self-report measures of pain than the SDC participants. It was also expected SDC+ participants 
would have greater improvement than the SDC participants on measures of overall perceived 
stress, pain severity, pain interference, psychological distress, sleep quality, and physical activity 
levels. Finally, we expected participants’ improvement on outcome measures, within the SDC+ 
condition, would be moderated by intervention engagement. Intervention engagement was 
quantified as the interaction of frequency of practices, duration of each practice, and overall 
treatment duration. 
Although the second study was modeled after two clinical trials that supported the use of 
diaphragmatic breathing skills training for persistent TMD symptom management (Carlson et al., 
2001; Schmidt et al., 2013), we anticipated the potential impact of several confounding factors. 
Previous research indicated a critical intervention dosage of 30 minutes of breathing practice per 
day on average is necessary to obtain significant improvement on measures of symptom severity 
(Schmidt et al., 2013). We attempted to mitigate this concern through the use of monetary 
incentives described below. In addition, similar clinical trials restricted treatment length to two 
weeks (Schmidt et al., 2012; Schmidt et al., 2013) instead of allowing treatment length to vary 
based on the dental treatment plan. Although imposing arbitrary treatment lengths may limit 
generalization to standard dental treatment practices, a specific treatment length may improve 
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treatment adherence and limit participant attrition. Another concern was whether TMD symptom 
severity would follow either a persistent or recurrent pattern. If participants suffer from recurrent 
TMD rather than persistent TMD, a longitudinal clinical trial may be vulnerable to recidivism of 
symptom severity. The concern is not easily addressed but semi-standardized endpoints were 
used in Study Two to mitigate any potential effects from recurrent TMDs. 
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Chapter Two: Study One Methodology 
 All procedures were approved by the University of Kentucky internal review board and 
all participants agreed to participate via an informed consent protocol. The study investigated the 
effects of two breathing entrainment approaches on HRV indices, a behavioral measure of self-
regulation, and questionnaires of state mindfulness. A mixed model design was used. The 
between-subjects factor was participant assignment to either the mindfulness breathing condition 
(MB), diaphragmatic breathing condition (DB), or the Nolen-Hoeksema attention activity 
condition (C). The within-subjects factor was measurement of HRV and additional physiological 
measures during the five-minute baseline recording (BL), during six-minute condition specific 
skills practice session (PRAC), and during a 16-minute lab based measure of behavioral self-
regulation with a cued go/no-go test (CT). At baseline, participant demographics and state levels 
of mindfulness were recorded.  
Participants and Recruitment Methods 
Participants consisted of 90 University of Kentucky undergraduate students who were 
self-selected volunteers screened for the inclusion criteria set forth below. Given the focus on 
respiration, autonomic nervous system modulation through breathing training, and evaluation of 
participants’ capacity to sustain attention and regulate their inhibitory control, participants were 
screened for pertinent medical conditions. All participants were screened for the presence of 
chronic respiratory conditions (e.g. asthma, COPD), hypertension, gastrointestinal disorders, or 
neurodevelopmental disorders (e.g. ADHD) through self-report questions prior to study inclusion. 
Volunteer participants reporting these conditions were excluded from the project. Given the use 
of colored cues in the lab test of behavioral self-regulation, participants were also screened for 
self-reports of color-blindness and excluded if color blindness was indicated.  
Treatment Conditions 
Participants in the MB, DB, and C conditions were provided directions with audio and 
visual prompts with an in-room computer. Instruction lasted between six and seven minutes and 
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pre-recorded scripts were used (see script samples below). Participants were asked to practice the 
condition specific technique for five minutes during a skills practice session.  
Participants in the DB condition were instructed on how to breathe from the diaphragm 
muscle and follow a 4-2-4 breathing pace (inhale for 4 seconds, exhale for 2 seconds, pause for 4 
seconds). MB participants were instructed on how to observe the movements and sensations of 
their breathing in a nonjudgmental way. No specific instructions on mechanics or pace of 
breathing were provided. C participants were asked to imagine and focus on a series of objects 
and settings, to serve as a distracting manipulation that is cognitively engaging but not focused 
specifically on breathing. 
Mindfulness Breathing Meditation. “We are very interested in understanding your 
responses to the study procedures. We will guide you through focusing your attention on your 
breathing, such as noticing the way your breath flows in, fills your lungs, and exits your body. 
This mindful awareness, or mindful breathing, will be the next part of today’s study experience.” 
“Please begin by making yourself comfortable in the chair. Coming away from the back 
of the chair so your spine can be self-supporting, so that your back, and neck, and head are in line 
in an erect posture, but not stiff. The shoulders can be dropped and relaxed, so that your posture 
embodies a sense of dignity, a sense of being awake, aware, in touch with this moment, and 
letting your eyes close, with smooth eyelids and smooth forehead. Your arms resting at your sides 
or in your lap, in whatever way feels comfortable.” (Pause for 5 seconds) 
“Coming now to focus on your breathing. Focusing on wherever you feel the breath 
moving most distinctly, in and out of your body. This may be at the tip of the nose, the back of 
the throat, or the chest, or down in the belly, down in the abdomen, as it rises on the in-breath, 
and falls away on the out-breath. Noticing, precisely, the sensations that accompany each in-
breath and each out-breath. Each breath is unique; each has different sensations. Simply tuning 
into each one in its own time, giving each its own attention. Just this breath coming in. Just this 
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breath going out. Allowing the breath to anchor you in the present moment.” (Pause for 10 
seconds) 
“And bringing your mind back to the present breath whenever you notice it’s wandered 
away. And this may happen many times. And just as often as it happens, then very gently 
bringing it back. Sometimes the mind wanders for a few moments, and sometimes it wanders for 
a long time. And it’s possible to find yourself judging and criticizing yourself for the wandering 
mind. But that’s what minds do. And so, the task is not to try to still or clear the mind of any 
thoughts, but simply to notice what it’s doing, and then gently bringing it back when you notice 
that it’s wandered. So, if that happens, many times, bringing it back, just as many times, 
beginning over and over and over again, with the next in-breath or the next out-breath. And using 
the stretches of silence to carry on this work by yourself (Pause for 20 seconds). And now, 
expanding your awareness around the breath, so that you’re aware of the sensations as your 
breath fills your body. Allowing yourself to be open to these sensations, so that you’re able to feel 
what’s here, right now. What sensations are you feeling with your breath in the moment?” (Pause 
for 10 seconds) 
“And if your attention wanders from the breath, from these sensations, at any point, 
coming back to being aware of the breath and the sensations here, in this moment… and in this 
moment… and in this moment.” (Pause for 20 seconds) “And remembering that this sense of 
being present is available to you at any moment. By reconnecting with your breath, reconnecting 
with what’s going on right now, moment by moment.” 
A similar pattern of prompts outlined above was provided during the five-minute skills 
practice session. Prompts occurred at 20- to 30-second intervals. 
Diaphragmatic Breathing Training. “We are very interested in understanding your 
responses to the study procedures. We will help you change your breathing so that the stomach is 
moving in and out rather than breathing with your chest, as research has shown that this can help 
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you relax better. This is called “belly breathing,” or “diaphragmatic breathing,” and it can help 
you relax and maintain calmness in today’s study experience.”  
“Please remember the rule: you should do nothing to increase your sense of discomfort 
while you are practicing the breathing. To start breathing with your stomach, or diaphragm, you 
should rest in a comfortable position with your head centered, supported, and in the midline of 
your body. Your eyes are relaxed, with smooth eyelids, and smooth forehead. Your mouth is 
relaxed, with lips apart, teeth apart, and tongue relaxed. There’s no throat movement. Your 
shoulders are sloped and even, elbows bent. Your hands will be in a curled relaxed position, not 
touching one another, knees are apart, and feet are pointing away from one another at a 45- to 90-
degree angle. Then, place your right hand just below your rib cage on top of your stomach. Just 
exhale first to release air from your body. It should be a complete, relaxed release where there is 
no holding, controlling, or forcing of the release. It is like a balloon collapsing as you let your air 
go from your body. When you are ready to take your next breath of air in, let the stomach gently 
rise as if you are pushing your stomach up with the column of air coming in. After you take in a 
comfortable, normal breath, release your muscles and let the air go just as you did at first when 
you started the exercise. There is no controlled, gradual release, just let go all at once and have 
the air move naturally out of your body. Then, pause and rest for a few moments before you take 
air in again to start another breath cycle. The rest period between breaths is the deepest point of 
your relaxation when everything is quiet and you relax before taking air in again (Pause for 10 
seconds). From the beginning of this training, you should breathe at a pace that makes you feel 
comfortable (Pause for 5 seconds). You also want to breathe naturally and not too deeply in order 
to avoid over-breathing or hyperventilation. If you were to feel light-headed or dizzy, chances are 
you are taking in too much air with each breathe. Take a little less air in on your next breath and 
the breaths that follow (Pause 10 seconds). Most people find that counting to 4 while air is 
coming into your lungs may set a natural, relaxed pace. Once the air is released, the rest period is 
typically the time it takes to count from 1 to 4. So, a starting pace for you can be counted as [air 
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in-2-3-4, release, and rest-2-3-4] (Phrase repeated twice). Repeat this breathing pattern for several 
minutes to establish a comfortable, relaxed rhythm to your breathing (Pause for 5 seconds). Let 
your stomach rise as air enters, then let the stomach fall as you release the air, and let everything 
rest until taking in your next breath of air (Pause for 10 seconds). Your breathing rate will likely 
be somewhere between five to six breaths per minute as you practice diaphragmatic breathing. 
Let your breathing be slow and relaxed as your stomach moves up and down.” 
Participants were provided a visual aid to assist with pacing during the five-minute skills 
practice session. An oval was displayed on the in-room computer that expanded, contracted, and 
remained still at the suggested breathing pace. No verbal direction was given during the skills 
practice session.  
Nolen-Hoeksema Task. The control group participated in the Nolen-Hoeksema attention 
activity. The activity asked participants to shift their attention amongst a series of imagined 
objects or places and has been used as an effective attention control (adapted from Nolen-
Hoeksema & Morrow, 1993). The introduction began:  
“For the next few minutes, try your best to focus your attention on each of the 
ideas. As you listen to the items, use your imagination and concentration to focus your 
mind on each of the ideas. Spend a few moments visualizing and concentrating on each 
item. Please continue until the experimenter returns. Think about and imagine a boat 
slowly crossing the Atlantic (~10 second pause). Think about the layout of a typical 
classroom (~10 second pause). Think about the shape of a large black umbrella.” 
The pattern of prompts continued for the duration of the skills training session. A 
similar introduction with a new set of prompts was used during the five-minute skills 
practice session.  
Dependent Measures 
Demographic Information. Participants provided information on their age, year in 
school, race, dominant hand, and past meditation experience.  
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Five Facet Mindfulness Questionnaire (FFMQ). The FFMQ is a 39-item instrument 
used to assess components of mindfulness and forms five subscales: observing, describing, acting 
with awareness, non-judging of inner experience, and non-reactivity to inner experience (Baer et 
al., 2008). The FFMQ has demonstrated good consistency ratings, Cronbach’s α = 0.87 (Baer et 
al., 2008). FFMQ items are coded on a 1- to 5-point scale, with response options of: 1 = Never or 
very rarely true, 2 = Rarely true, 3 = Sometimes true, 4 = Often true, and 5 = Very often or 
always true.  
Breathing. Breathing rate and mechanics were recorded with a BSL-SS5LB respiratory 
effort transducer and amplifier module with a BioPac MP100 system (Goleta, CA). The sensor 
was placed around the abdomen below the rib cage and above the navel to measure diaphragm 
engagement. Breathing rates were recorded as breaths-per-minute (BPM).  
Heart Rate Variability. ECG data were collected using a MP100 Biopac System, an 
ECG100B amplifier, and a three-electrode modified Lead II format. ECG was collected 
continuously with Acqknowledge software and analyzed with Mindware software (Gahanna, OH) 
in accordance with established guidelines (Berntson et al., 1997; Malik, 1996). Mindware 
software provides frequency HRV measures in the high frequency range, which is often 
associated with parasympathetically mediated effects on the heart (HF-HRV, .15 to .4Hz). It also 
provides time domain measures of HRV such as the square root of the mean squared differences 
of successive NN intervals (RMSSD) and the standard deviation of the NN intervals (SDNN). 
RMSSD and SDNN provide an index of parasympathetic tone on cardiac functioning unaffected 
by a participant’s respiration frequency range. We focused our investigation on the HF-HRV 
frequency range, RMSSD, and SDNN to assess the effects of each skills training condition on 
these indices of HRV (Berntson et al., 1997; Lehrer & Gevirtz, 2014; Vaschillo, Vaschillo, & 
Lehrer, 2006). 
Cued Go/No-Go Task. The cued go/no-go task was delivered through an in-room 
computer using E-Prime experiment generation software (Marczinski & Fillmore, 2003). Each 
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cued go/no-go trial followed this order: (1) the appearance of a fixation point (+); (2) a blank 
white screen for 500ms; (3) a cue image, presented for one of five stimulus onset asynchronies 
(SOAs = 100, 200, 300, 400, and 500ms); (4) a go or no-go target, which remained on the screen 
until a participant response was entered or 1,000ms elapsed; and (5) a brief inter-trial interval of 
700ms.  
The cue image was a rectangle (7.5cm X 2.5cm) framed by a 0.8mm black outline. The 
cue was presented in the center of the computer screen against a completely white background. 
Each cue image was presented in either a vertical (7.5cm X 2.5cm) or horizontal (2.5cm X 7.5cm) 
orientation for one of five SOAs. The go (color green) and no-go (color blue) targets were used to 
fill the interior of the outlined rectangle cue. Participants were instructed to respond or press the 
(/) key on the computer’s keyboard if the cue filled in with green. If the rectangle cue filled in 
with blue they were to suppress their response (not press any key). Keyboard presses were made 
with the participant’s index finger of their dominant hand.  
The cue image orientation (vertical or horizontal) signaled the probability that a go or no-
go target would be displayed. Vertically oriented cues preceded the presentation of go targets 
(green rectangle) on 80% of the trials and no-go targets (blue rectangle) on 20% of the trials. 
Horizontally oriented cues preceded no-go targets 80% of the time and go targets on 20% of the 
trials. The frequency of cue-target image pairings allowed the vertically and horizontally oriented 
rectangles to function as go and no-go cues, respectively. The SOAs ensured participants 
remained focused on the presentation of each new cue and prevented participants from 
anticipating the time lapse between cue and target presentation. A complete cued go/no-go test 
consisted of 250 individual trials with an equal number of the vertical (125) and horizontal (125) 
rectangle cues. In addition, a complete cued go/no-go test included an equal number of go (125) 
and no-go (125) target trials, with green and blue rectangles serving as the targets respectively. 
For each trial, the computer recorded whether a response occurred and the reaction time in 
milliseconds for that response.  
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The cued go/no-go task was used to evaluate the participant’s ability to inhibit impulses 
and behaviorally self-regulate. For the present study, we were interested in participants’ mean 
accuracy rates during the go cue and no-go target pairing as a measure of self-regulation. For a 
detailed description and explanation of the cued go/no-go task, please see Marczinski & Fillmore, 
2003. 
Procedures  
Participants were screened for inclusion criteria through email or a telephone call. Once 
screened, interested participants were scheduled for an appointment with a research assistant. 
Participants were randomly assigned to condition (MB, DB, or C) prior to the laboratory visit 
using a table of random numbers. Upon arrival at the laboratory, participants were provided 
informed consent, completed the demographics information, and the FFMQ.  
After completing the questionnaires, participants were connected to electrocardiogram 
equipment, a respiratory effort transducer, and they were then asked to sit quietly without 
movement or conversation for a five-minute physiological baseline recording. Next, based on the 
pre-determined experimental condition, participants were trained with six to seven-minute-long 
pre-recorded audio directions on MB, DB, or the C attention activity. For the DB condition a 
visual prompt was also provided to assist with participants’ matching the desired breathing rate. 
Following training, participants were given five minutes in a skills practice session that included 
auditory and visual prompts via an in-room computer. For example, participants trained on 
mindfulness breathing meditation were provided the following prompt during the five-minute 
practice period, “And if your attention wanders from the breath, from these sensations, at any 
point, coming back to being aware of the breath and the sensations here, in this moment…and in 
this moment…and in this moment.” HRV measures and breathing rates were recorded throughout 
the six-minute instruction period and the five-minute skills practice session.  
All participants then completed the cued go/no-go task as a measure of inhibitory control 
and behavioral self-regulation. Physiological measures of HRV and breathing rates were recorded 
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throughout the cued go/no-go task. Participants were debriefed and dismissed. All participants 
received course credit for study participation.  
Hypotheses 
The study aim was to compare the ability of three interventions (MB, DB, and C) to 
reduce breathing rates, increase HRV, and improve performance on a behavioral measure of self-
regulation (cued go/no-go task). For the first hypothesis, we anticipated the MB and DB 
conditions would show greater reductions in breathing rate than the C group during both the 
PRAC and CT recordings. In addition, it was anticipated the DB condition would show greater 
reductions in breathing rate than the MB condition across the PRAC and CT recordings. The 
second hypothesis predicted both the MB and DB conditions would show higher measurements 
on HRV incidences than the C condition during the PRAC and CT recordings, but the DB 
condition would show the most increases in HRV indices. For the third hypothesis, it was 
predicted the MB and DB conditions would have higher accuracy rates on the task of behavioral 
self-regulation (cued go/no-go) than the C group. The DB condition was also predicted to have 
higher accuracy rates than the MB condition on the behavioral self-regulation task (cued go/no-
go).  
HRV Cleaning and Interpretation  
ECG data were visually examined in 60-second tachograms without stage identifiers to 
avoid experimenter bias. Missing or erroneous heartbeats were cleaned according to the 
recommendations made by the Task Force and then expanded by the 1997 Committee Report 
(Berntson et al., 1997, p. 631; Task Force, 1996). Specifically, movement or aberrant heartbeats 
were visually examined and adjusted for by either measuring the actual R-R interval or 
interpolating the missing heartbeat. Movement artifacts where heartbeats were not clearly 
indicated were corrected with a mid-beat replacement. Double-marked R peaks and erroneous R 
peaks were removed. Based on recommendations from Mindware Technologies, 60-second 
tachograms with over 10% erroneous beats or tachograms that did not have at least 30 
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consecutive seconds of measurable data were not included in calculations. Following visual 
inspection, all participants within each of the three measurement periods had at least 60% of their 
60-second tachograms included in analyses. No HRV data were excluded.  
All physiological measures were recorded on a minute-by-minute basis. Overall averages 
were taken for each recording period. No physiological measures were excluded.  
Planned Statistical Analyses 
All analyses were conducted using IBM SPSS Version 24. No data were missing. All 
study variables were first checked for normality, homogeneity of variance, sphericity, and outliers 
using the criteria of three standard deviations. Outliers were identified across several 
physiological measures. In RMSSD two BL, two PRAC, and two CT outliers were identified. In 
SDNN, one BL, one PRAC, and one CT outlier were identified. No other outliers were found and 
all analyses were run excluding the identified outliers. Potential between condition differences in 
participant demographics or state mindfulness, as measured by the FFMQ, were assessed with a 
series of ANOVAs.  
Means and standard deviations were calculated for physiological variables during BL, 
PRAC, and CT measurements (Table 2.1). Significant baseline differences were found between 
conditions for HR and RMSSD. Therefore, mixed model repeated measures multivariate analyses 
of co-variance (RM-ANCOVAs) were conducted to investigate within-subject differences across 
study stage (PRAC and CT), between-subjects differences among conditions (MB, DB, and C), 
and interaction effects, while controlling for baseline differences between conditions. For all 
other physiological measures (BPM, HF-HRV, and SDNN) mixed model repeated measures 
multivariate analyses of variance (RM-MANOVAs) were used to investigate within-subjects, 
between-subjects, and interaction effects.  
For all analyses, condition was the between-subjects factor (MB, DB, and C) and study 
stage (BL, PRAC, and CT) was the within-subject factor or repeated measure. If sphericity was 
violated for either the RM-ANCOVAs or RM-MANOVAs, the Greenhouse-Geisser correction 
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was used. Univariate analyses and pairwise contrasts were used to investigate significant omnibus 
tests. To control for the number of comparisons, the Holm-Bonferroni method was used. The 
Holm-Bonferroni method is more precise than the overly conservative Bonferroni method, and is 
considered the most appropriate method to use when dependent variables are correlated with each 
other. For details of the Holm-Bonferroni method, see Aickin and Gensler (1996).  
Several participants had missing data for the behavioral self-regulation task (cued go/no-
go) from equipment malfunctions. Data were found missing for five MB, four DB, and four C 
participants. The data were considered missing at random. As the primary focus was on assessing 
the impact of the skills training on the participant’s ability to self-regulate during the cued go/no-
go task, our analyses focused on the go cue and no-go target pairing (Marczinski & Fillmore, 
2003). An ANOVA was used to investigate potential differences on mean accuracy rates between 
conditions (MB, DB, and C).  
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Table 2.1 
 
Means and Standard Deviations for all Physiological Measures in Study One 
 
 Baselines  Skills Practice Session  Cue Task Session 
 MB DB C  MB DB C  MB DB C 
Variable M (SD) M (SD) M (SD)  M (SD) M (SD) M (SD)  M (SD) M (SD) M (SD) 
BPM 14.65 
(3.33) 
15.28 
(3.40) 
14.62 
(3.14)  
12.46 
(4.23) 
7.54 
(3.30) 
15.08 
(3.20)  
16.04 
(3.16) 
15.87 
(2.82) 
16.32 
(2.61) 
HR 78.33 
(11.50) 
72.65 
(9.42) 
80.93 
(10.57)  
80.35 
(11.64) 
72.49 
(8.49) 
80.22 
(9.60)  
77.69 
(11.12) 
72.24 
(8.69) 
80.02 
(9.46) 
HF-HRV 6.37 
(1.00) 
6.94 
(1.04) 
6.48 
(0.73)  
6.25 
(1.15) 
7.16 
(0.94) 
6.15 
(1.07)  
6.12 
(0.92) 
6.70 
(0.90) 
6.10 
(0.97) 
RMSSD 36.79 
(14.70) 
58.34 
(22.60) 
39.45 
(15.45)  
38.26 
(20.01) 
67.68 
(26.85) 
36.45 
(18.44)  
41.76 
(17.26) 
59.45 
(26.25) 
43.02 
(19.98) 
SDNN 54.68 
(14.52) 
64.63 
(22.65) 
54.41 
(16.31)  
61.71 
(26.13) 
97.34 
(28.26) 
49.73 
(21.97)  
58.91 
(18.34) 
66.37 
(20.46) 
58.91 
(18.34) 
Note: N = 90. MB = Mindfulness Breathing Condition; DB = Diaphragmatic Breathing Condition; C = 
Nolen-Hoeksema Condition; BPM = breaths-per-minute; HR = heart rate measured as the number of beats in 
60 seconds; HF-HRV = High frequency heart rate variability (.15 to .4Hz); RMSSD = root mean squared of 
the successive differences between adjacent NN peaks measured in milliseconds; SDNN = standard deviation 
in NN interval measured in milliseconds. 
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Chapter Three: Study One Results 
Participant Demographics 
Participants consisted of 90 University of Kentucky undergraduate students. Participants 
were randomly assigned to a study condition upon arrival. Thirty participants were included in 
each condition. During the study, no participants discontinued or failed to finish all study 
measures. Demographic information for each condition including previous experience with 
meditation practices and state levels of mindfulness are presented in Table 3.1. No significant 
differences between conditions were found across all demographic variables or the measure of 
state mindfulness, p’s > .05. 
Effect of Intervention on Outcomes 
 Omnibus tests for HR indicated a multivariate interaction between study stage and 
condition, Wilks’ Lambda: F(1,86) = 4.13, p = .02, ƞ2 = .09. Follow-up univariate analyses 
showed a significant effect of condition within the PRAC session, F(2,86) = 4.08, p = .02, ƞ2 = 
.09. Pairwise contrasts indicated participants within the MB condition had significantly higher 
HR during the PRAC session than participants in the DB condition but were not significantly 
different than the C condition. Participants in the DB and C conditions did not have significantly 
different HR measurements. Means and standard deviations for all physiological variables are 
presented in Table 2.1.  
Omnibus tests for RMSSD indicated a significant interaction between study stage and 
condition, Wilks’ Lambda: F(2,83) = 8.38, p < .001, ƞ2 = .17. Specifically, during the PRAC 
session, RMSSD was significantly higher in the DB condition than the C condition but not 
significantly different than the MB condition (Table 3.2). No significant difference on RMSSD 
was found between the MB and C conditions.  
Omnibus tests for BPM indicated a significant effect of study stage, Wilks’ Lambda: 
F(2,86) = 58.58, p < .001, ƞ2 = .58, and an interaction between study stage and condition, Wilks’ 
Lambda: F(4,172) = 15.94, p < .001, ƞ2 = .27. Follow-up univariate analyses indicated a 
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significant effect of condition within the PRAC session, F(2,87) = 33.84, p < .001, ƞ2 = .44. 
During the PRAC session, pairwise contrasts indicated BPM was significantly lower in the DB 
condition than both the MB and C conditions. BPM was also significantly lower in the MB 
condition than the C condition (Table 3.2).  
Omnibus tests for HF-HRV indicated a significant effect of study stage, Wilks’ Lambda: 
F(2,86) = 10.13, p < .001, ƞ2 = .19. There was also a significant within-subjects effect for study 
stage, F(2,174) = 7.73, p < .001, ƞ2 = .08 and a significant within-subjects interaction between 
study stage and condition, F(4,174) = 2.54, p < .05, ƞ2 = .06. Follow-up univariate analyses 
indicated a significant effect of condition within the PRAC session, F(2,87) = 33.84, p < .001, ƞ2 
= .44. During the PRAC session, pairwise contrasts showed HF-HRV was significantly higher in 
the DB condition than both the MB and C conditions. HF-HRV was not significantly different 
between the MB and C conditions (Table 3.2).  
Omnibus tests for SDNN indicated a significant effect of condition, Wilks’ Lambda: 
F(2,85) = 21.54, p < .001, ƞ2 = .34, and an interaction between study stage and condition, Wilks’ 
Lambda: F(4,170) = 19.36, p < .001, ƞ2 = .31. Follow-up univariate analyses indicated a 
significant effect of condition within the PRAC session, F(2,87) = 18.95, p < .001, ƞ2 = .30. 
During the PRAC session, pairwise contrasts showed SDNN was significantly higher in the DB 
condition than both the MB and C conditions. No difference was found on SDNN between the 
MB and C conditions (Table 3.2).  
ANOVA analyses on mean accuracy rates within the cued go/no-go task suggested 
participants’ in the MB condition (M = 94.04%, SD = 10.69), DB condition (M = 93.38%, SD = 
7.24), and C condition (M = 95.38%, SD = 7.73), did not significantly differ from one another, 
Wilks’ Lambda: F(4,148) = 0.18, p = .95, ƞ2 = .005.  
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Table 3.1 
 
Demographic Characteristics of Participants in Study One 
 
 MB Condition  DB Condition  C Condition 
Demographic 
Variables  M (SD) % 
 
M (SD) % 
 
M (SD) % 
Age  19.53 (1.96)   19.30 (1.90)   19.23 (3.01)  
Year in School          
   Freshman  66.7   66.7   73.3 
   Sophomore  16.7   23.3   16.7 
   Junior  13.3   6.7   6.7 
   Senior  3.3   3.3   3.3 
Race         
   Caucasian or White   70.0   66.7   66.7 
   African American   13.3   6.7   16.7 
   Asian American   6.7   16.7   10.0 
   Hispanic or Latino   3.3   0.0   3.3 
   Other   6.7   10.0   3.3 
Gender         
   Female   76.7   86.7   80.0 
   Male  23.3   13.3   20.0 
Meditate Weekly         
   No  100   100   96.7 
Previous Meditation          
   None  76.7   76.7   86.7 
   A Little  20.0   20.0   10.0 
   A Medium Amount  3.3   3.3   3.3 
FFMQ Scales         
   Observing 26.33 (6.09)   25.57 (4.49)   24.93 (4.17)  
   Describing 23.93 (2.61)   23.17 (3.49)   24.13 (2.96)  
   Act w/Awareness 18.47 (3.31)   18.40 (3.10)   18.47 (2.84)  
   Non-Judge  17.37 (3.99)   16.97 (2.92)   18.00 (2.92)  
   Non-Reactivity 22.47 (3.62)   22.47 (3.74)   21.03 (3.55)  
Note: N = 90. MB = Mindfulness Breathing; DB = Diaphragmatic Breathing; C = Nolen-
Hoeksema; Previous Meditation = Past Meditation Experience; FFMQ = Five Facet Mindfulness 
Questionnaire (Baer et al., 2008); Non-Judge = Non-Judge of Inner Experience. 
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Table 3.2 
 
Pairwise Contrasts Between Conditions 
 
Variable Condition 
Comparison 
Condition 
Mean 
Difference S.E. p 
BPM C 
C 
MB 
MB 
DB 
DB 
2.62 
7.54 
4.92 
0.93 
0.93 
0.93 
  .018 
 < .001 
< .001 
HR C 
C 
MB 
MB 
DB 
DB 
    -2.39 
0.62 
3.00 
1.11 
1.16 
1.13 
  .10 
   1.00 
   .028 
HF-HRV C 
C 
MB 
MB 
DB 
DB 
-0.11 
-1.02 
-0.91 
0.27 
0.27 
0.27 
   1.00 
  < .001 
  .003 
RMSSD C 
C 
MB 
MB 
DB 
DB 
-1.77 
-9.78 
-8.01 
3.50 
3.69 
3.80 
1.00 
  .029 
.11 
SDNN C 
C 
MB 
MB 
DB 
DB 
-14.59 
-45.38 
-30.79 
7.53 
7.53 
7.53 
.17 
  < .001 
  < .001 
Note: N = 90. Significant pairwise contrasts are bolded. C = Nolen-
Hoeksema Condition; MB = Mindfulness Breathing Condition; DB = 
Diaphragmatic Breathing Condition; BPM = breaths-per-minute; HR = 
heart rate measured as the number of beats in 60 seconds; HF-HRV = 
High frequency heart rate variability (.15 to .4Hz); RMSSD = root 
mean squared of the successive differences between adjacent NN peaks 
measured in milliseconds; SDNN = standard deviation in NN interval 
measured in milliseconds; p’s significant < .017.  
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Chapter Four: Study One Discussion 
Interpretation of Results 
During the PRAC session, participants in the DB condition had significantly lower BPM 
than participants in the MB or C conditions. The DB condition also elicited greater improvement 
than the MB or C conditions in HF-HRV and SDNN but not RMSSD. Results predominantly 
supported hypotheses one and two, which indicated the DB condition would result in greater 
BPM reductions and greater increases in HRV indices than the MB or C conditions. Yet, results 
suggested no condition provided an effect on HRV indices and respiration rates strong enough to 
persist past the PRAC session. Overall, results suggested diaphragmatic breathing techniques are 
more effective than mindful breathing techniques at increasing physiological variables associated 
with PNS activation, while the stability of the effect may be limited. The limited effect for both 
the DB and MB conditions is understandable given the brief nature of training (five to six 
minutes) as well as the single practice session of five minutes, and is consistent with previous 
literature (Evans et al., 2014). Previous literature has shown more practice in self-regulation skills 
leads to a more stable change (Muraven, Baumeister, & Tice, 1999; Schmidt et al., 2013). It 
would be important to consider the dose level of practice necessary to produce a meaningful and 
lasting effect on breathing rate, HRV indices, and measures of behavioral self-regulation.  
Inconsistent with hypothesis three, no differences were found between conditions on 
mean accuracy rates during the cued go/no-go task. The lack of between group differences may 
be a consequence of the breathing practice effects in all conditions failing to persist into the CT 
session. In addition, the cued go/no-go task appeared to suffer from ceiling effects as no condition 
had a mean accuracy rate below 93%. Future research should focus on populations known to have 
self-regulatory deficits or consider the use of additional behavioral self-regulation tasks shown to 
have greater discriminability between healthy individuals who are able to self-regulate normally.  
In addition, the effects of multiple skills training sessions on prolonging the positive 
effects of the breathing interventions should be explored. As the mindfulness based breathing 
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meditation showed partial activation of PNS tone consistent with previous literature, additional 
practice may elicit greater improvement (Burg et al., 2012). Previous literature suggests one 
potential cause for the lack of a prolonged effect of skills training on HRV indices is initial 
training on self-regulatory skills may overwhelm an individual’s self-regulatory resources instead 
of bolstering them (Evans, Eisenlohr-Moul, Button, Baer, & Segerstrom, 2014). Participants 
splitting resources between using the newly learned skills and the cued go/no-go task may have 
negatively impacted HRV indices during the CT recording period. With additional training, 
perhaps participants could build up their self-regulatory resources and their skill in the use of the 
MB or DB breathing techniques. As literature supports the use of both breathing interventions for 
PNS activation, future work should consider factors to identify the effective dose level including 
the ideal number of practices, the frequency of practice, and the duration of each practice required 
to generate a lasting effect on HRV indices (Burg et al., 2012; Carlson et al., 2001; Grossman et 
al., 2004; Krygier et al., 2013; Schmidt et al., 2013). In addition, the feasibility of participants 
adhering to a behavioral treatment regimen, the tolerability of the intervention, and the clinical 
efficacy should all be considered. However, when limited to a single session, overall results 
suggested a CBT based didactic approach teaching slow diaphragmatic breathing is most 
effective at increasing physiological indicators of PNS tone when compared to MB based 
intervention. 
To explore further the effectiveness of the DB intervention for increasing PNS tone and 
producing a clinically meaningful effect with individuals suffering chronic autonomic nervous 
system dysregulation, an mHealth app was created with the DB training protocol outlined above. 
The mHealth app included audio directions and a visual pacing aid to guide a participant’s 
breathing pace. In an effort to assess the mHealth app’s efficacy to improve PNS tone within a 
population know to suffer from self-regulatory deficits, the app was distributed to patients 
seeking treatment for persistent TMDs. As an underlying risk factor for the onset and persistence 
of TMDs is PNS dysregulation, the present project focused on evaluating the ability of the 
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mHealth app to improve PNS tone. In addition, Study Two compared the combination of the 
mHealth app with standard dental treatment (SDC+) to standard dental treatment alone (SDC). 
By comparing the combination treatment to the standard practice, it was hoped the benefits of 
addressing the underlying PNS dysregulation so common in persistent TMDs would be made 
clear (Fillingim et al., 2011; Maixner et al., 2011a). 
Study Two was structured as a phase one clinical trial with the goals of demonstrating at 
least a minimal effect on the primary outcome variables of BPM, HRV indices, and self-report 
measures of pain. The study examined the dose level of the mHealth app, its feasibility, and its 
tolerability. In order to examine the effects of dose level, the mHealth app was created with 
features to track the participant’s frequency and duration of use. It was hoped tracking 
participants’ frequency and duration of practice would highlight a cut score for the amount of 
practice necessary to achieve a maximum clinical effect. Feasibility and tolerability was assessed 
through considering the chosen recruitment methods, reinforcement schedule for adherence to the 
intervention’s protocol, and participants’ responses to the SDC+ versus the SDC intervention.  
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Chapter Five: Study Two Methodology 
All procedures were approved by the University of Kentucky internal review board and 
all participants agreed to the study via an informed consent protocol. The study investigated 
whether the inclusion of a mobile phone application teaching diaphragmatic breathing with 
standard dental care significantly improved treatment outcomes for persistent TMDs above 
standard dental care alone. Although a between-subjects design was used, given the low 
participant number, data were viewed as exploratory. Data were not used to make causal 
inferences but rather to guide future research.  
Participants and Recruitment Methods 
 All 19 participants were recruited from patients seeking dental care at the University of 
Kentucky’s Orofacial Pain Clinic (OFPC) between August 2016 and July 2017. Licensed dentists 
screened participants in accordance with Research Diagnostic Criteria for a primary diagnosis of 
myalgia. All participants reported a primary pain duration of at least three months and a self-
reported current pain level of at least 30mm on a 0 to 100mm visual analog scale for pain (VAS). 
Participants were also screened by a series of self-report questions and medical history review for 
several health conditions. Participants were excluded if they reported a history of heart disease, 
current use of cardiovascular medications (e.g. beta-blockers), a history of asthma or other 
chronic respiratory conditions (e.g. COPD), diabetes (Type 1 or 2), current pregnancy, or a 
history of hypertension.  
Standard Dental Treatment Plus App (SDC+) 
Participants were not restricted from receiving any dental interventions. Upon 
recruitment, participants were provided a brief orientation to the functioning of an iPod and the 
mHealth app. The protocol was discussed and the participant’s concerns or questions were 
addressed. Participants were provided an iPod Touch with the mHealth app installed, a handout 
outlining how often and how long to practice with the mHealth app, and a packet of VAS and RR 
scales. Participants were asked to practice with the mHealth app at least once in the morning and 
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once in the evening. The length of the practices started at five minutes each and titrated upwards 
over the course of their participation by one minute each day until it reached a maximum length 
of 20 minutes. Participants were asked to complete VAS and RR ratings before and after each 
mHealth app practice. Thereby, a daily average for VAS and RR was recorded in addition to 
change scores for VAS and RR from before to after mHealth app use. Participants were scheduled 
for a follow-up visit by clinic staff from two to eight weeks after their initial clinic appointment. 
If participants failed to attend their follow-up visit, study staff contacted participants in an attempt 
to reschedule them for completion of visit two study procedures.  
Participants were provided with directions for using an online survey system (Qualtrics). 
Qualtrics was used to complete weekly questionnaires on pain, sleep, physical activity levels, and 
psychological symptoms. Participants were asked to provide a working email address to receive 
survey links. If participants did not have easy access to email, they were provided with paper 
copies of the questionnaires. 
The mHealth app was based on a computer delivered entrainment protocol previously 
validated through a series of studies (Russell, Hoffman, Stromberg, & Carlson, 2014; Russell et 
al., 2016). The mHealth app consists of audio guidance on slow paced diaphragmatic breathing 
and a visual pacing aid. The visual pacing aid consisted of an oval that expands for four seconds 
during inhalation, contracts for two seconds during exhalation, and remains still during the four-
second rest phase. The mHealth app tracked participants’ frequency of app use and the duration 
of each use to facilitate a measurement of participants’ treatment adherence.  
Standard Dental Treatment Alone (SDC) 
Participants were not restricted from receiving any dental based intervention. Participants 
were informed they would receive dental treatment and be asked to track their pain and levels of 
relaxation over the course of their treatment using VAS and RR scales. The protocol was 
discussed and the participant’s concerns or questions were addressed. Participants were not 
directly informed they were in the experiment’s control condition. Participants were provided a 
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packet of VAS and RR scales. They were asked to complete a VAS and RR scale every morning 
and evening during their treatment. Participants were scheduled for a follow-up visit by clinic 
staff from two to eight weeks after their initial clinic appointment. If participants failed to attend 
their follow-up visit, study staff contacted participants in an attempt to reschedule them for 
completion of visit two study procedures.  
Participants were provided with directions on using Qualtrics. Qualtrics was used to 
complete weekly questionnaires on pain, sleep, physical activity levels, and psychological 
symptoms. Participants were asked to provide a working email address to receive survey links. If 
participants did not have easy access to email, they were provided with paper copies of the 
questionnaires. 
Dependent Measures 
Demographic Form. Information regarding the participant’s dental diagnoses, dental 
treatment plan, medications (prescription), age, ethnicity, relationship status, employment status, 
previous breathing training, previous meditation experience, and previous relaxation training was 
collected. Participants were asked to update their medications at the second OFPC visit.  
Visual Analogue Scale for Pain (VAS). A VAS scale was used to assess the 
participant’s daily ratings of pain severity (Gracely, 1983). Participants marked their responses on 
a 100mm line where “0” and “100” were respectively anchored with the descriptors “no pain” 
and “the worst pain imaginable.” Previous studies have validated the use of a VAS to assess pain 
intensity and the use of the descriptive anchors with TMD patients (Burckhardt & Jones, 2003; 
Gracely, 1983; McMillan, Nolan, & Kelly, 1997). A ruler was then used to quantify the mark, 
resulting in scores ranging from 0 to 100. All participants completed a baseline VAS. SDC 
participants completed a VAS twice per day (morning and evening) and SDC+ participants were 
asked to complete a VAS before and after the morning and evening practices with the iPhone 
application.  
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Relaxation Ratings Scale (RR). A one-item numerical rating scale was used to measure 
self-reported feelings of relaxation. Participants marked their responses on a 100mm line where 
“0” and “100” were respectively anchored with the descriptors “not relaxed” and “very relaxed.” 
The scale has not been used with patients suffering persistent TMDs previously; therefore, results 
related to the RR scale should be interpreted cautiously. 
Perceived Stress Scale (PSS). The PSS consists of 10 items and a 0 = never to 4 = very 
often scale to assess the degree to which an individual perceives their stress as negative, 
unpredictable, uncontrollable, and overloading (Cohen, Kamarck, & Mermelstein, 1983). 
Individual scores on the PSS range from 0 to 40 with higher scores indicating higher perceived 
stress. Scores ranging from 0 to 13 would be considered low stress, 14 to 26 moderate stress, and 
27 to 40 high perceived stress. It has demonstrated good internal reliability and validity, 
Cronbach’s a = 0.78.  
Chronic Pain Grade Scale (CPGS). The CPGS uses seven items and a 0 = no change to 
10 = extreme change scale to classify chronic pain patients into four hierarchical categories 
(Grade 0 to Grade 4) based on pain severity and the pain’s interference with their life (Smith et 
al., 1997; Von Korff, Ormel, Keefe, & Dworkin, 1992). Grade 0 is no TMD pain in prior six 
months, Grade 1 is low disability-low intensity, Grade 2 is low disability-high intensity, Grade 3 
is high disability-moderately limiting, and Grade 4 is high disability-severely limiting. In 
previous studies, the CPGS’s Cronbach’s a > 0.8 (Smith et al., 1997). 
Patient Health Questionnaire 4 (PHQ-4). The PHQ-4 is a four-item measure that 
evaluates participants’ symptoms of depression and anxiety (Kroenke, Spitzer, Williams, & 
Löwe, 2009). Scores range from 0 = normal to 12 = severe symptoms of depression and anxiety. 
Internal consistency scores are considered strong, Cronbach’s a = 0.85 (Kerper et al., 2014; 
Kroenke et al., 2009). 
Pittsburgh Sleep Quality Index (PSQI). The PSQI is a 19-item questionnaire that 
examines the individual’s sleep quality (Buysse, Rynolds III, Monk, Berman, & Kupfer, 1989). 
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Information is gathered on the hours spent in bed, how frequently the individual is awoken, and 
the number of hours sleeping each night. Internal consistency was previously recorded as 
Cronbach’s a = 0.83 (Buysse et al., 1989). PSQI total scores were used for analyses. Total scores 
incorporated information on sleep duration, disturbances, latency, day time dysfunction due to 
poor sleep, efficiency, overall quality, and medication use for sleep. Total PSQI scores ranged 
from 0 = better sleep to 21 = worse sleep. 
Godin Leisure-Time Exercise Questionnaire (LSI). The LSI is a four-item 
questionnaire examining leisure time exercise habits. Participants reported on their exercise 
frequency, duration, and intensity (mild, moderate, or strenuous) over the past week (Godin & 
Shephard, 1997). The following formula is used to calculate scores: weekly leisure activity score 
= (9 × Strenuous) + (5 × Moderate) + (3 × Light), where the words “Strenuous,” “Moderate,” and 
“Light” are replaced by the number of times an individual engages in activities classified within 
each category. Two-week test–retest reliability coefficients for mild, moderate, and strenuous 
exercise were 0.48, 0.46, and 0.94, respectively (Godin & Shephard, 1997). 
Louisville Older Person Events Scale (LOPES). The LOPES is a 54-item life events 
scale developed with Kentucky older adults that measures significant life events occurring over 
the past six months in seven categories: family/relationships, home/household, legal 
matters/police, work/school, financial, own health, and significant others’ health (Murrell et al., 
1984). The questionnaire was used to assess for significant life stressors occurring during 
participation.  
Participant Self-Report on Efficacy and Tolerability of the mHealth App. 
Participants were asked a total of ten questions. The first five statements provided feedback on 
the perceived efficacy of the mHealth app; “The mobile application taught me how to breathe 
diaphragmatically,” “The instructions on how to breathe were clear,” “The instructions on the 
pace of breathing were clear,” “The breathing pace was relaxing,” and “If I have/had a friend 
with chronic pain, I would recommend this application.” Each statement used a Likert-type scale 
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of 0 to 100 with 0 = strongly disagree and 100 = strongly agree. Higher values indicate greater 
confidence in the efficacy of the mHealth app.  
Participants were then asked to provide information about their perceived frequency of 
practice; “How often were you able to practice breathing with the application?” Responses 
options included A = two or more times a day, B = once a day, C = 3-6 times a week, and D = 
less than three times a week.  
The last four questions were used to collect qualitative data from participants to assess 
the mHealth app’s tolerability and to guide future changes to the protocol. Items included; “What 
was the major issue keeping you from practicing more frequently,” “What was the major issue 
keeping you from practicing for longer periods of time,” “What was the most helpful aspect of 
the application,” and “What would you like to see changed or improved?”  
Breathing. Breathing rate and mechanics were recorded with two BSL-SS5LB 
respiratory effort transducers and two amplifier modules with a BioPac MP100 system (Goleta, 
CA). The first sensor was placed around the abdomen below the rib cage and above the navel to 
measure diaphragm engagement. The second sensor was placed around the chest such that the 
upper edge of the belt passes just underneath both armpits to measure thoracic muscle 
engagement. Breathing rates were recorded as breaths-per-minute. Diaphragm engagement during 
breathing was measured with a ratio score for movement of the diaphragm sensor versus the 
thoracic sensor.  
Heart Rate Variability. ECG data were collected using a MP100 Biopac System, an 
ECG100B amplifier, and a three-electrode modified Lead II format. ECG was collected 
continuously with Acqknowledge software and analyzed with Mindware software (Gahanna, OH) 
in accordance with established guidelines (Berntson et al., 1997; Malik, 1996). Mindware 
software provides frequency HRV measures such as high frequency (HF-HRV, .15 to .4Hz), low 
frequency (LF-HRV, .04 to .15Hz), very low HRV (VLF-HRV, .003 to .04Hz), and LF/HF ratios. 
It also provides time domain measures of HRV such as the standard deviation of the NN intervals 
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(SDNN) and the square root of the mean squared differences of successive NN intervals 
(RMSSD). Given our stated goal of slowing patients’ respiration rates into the low frequency 
range of 2.4 to 9 breaths-per-minute, we focused our investigation on the HRV frequency range 
and time domain measures that best captured respiratory sinus arrhythmia (Berntson et al., 1997; 
Lehrer & Gevirtz, 2014; Vaschillo, Vaschillo, & Lehrer, 2006). 
End Tidal CO2 (ETCO2). ETCO2 represents the partial pressure of carbon dioxide 
within an exhaled breath and is an indirect, but reliable, measure of alveolar CO2. As ETCO2 
decreases, O2 is less able to disassociate from hemoglobin and adequately oxygenate body tissues 
thereby increasing muscle fatigue and increasing pain perception (Fried & Grimaldi, 1993, p. 29-
44, p. 255, p. 176-227). An average ETCO2 was calculated during the participant’s physiological 
evaluation with a Capnocheck II Hand-Held Capnograph Detector (Dublin, OH) with a nasal 
cannula. Patients were asked to exhale only through the nose during recordings.  
Procedures 
All participants were new patients seeking treatment at the OFPC. As part of standard 
dental care at the OFPC, new patients provided a medical history and underwent a dental exam. 
After it was determined patients met inclusion criteria, they were approached by study personnel 
to discuss participation. Interested patients were provided informed consent.  
The first four participants were assigned to the SDC+ condition to serve as a feasibility 
trial. Of the four participants, three returned for a second OFPC visit. Following the initial 
feasibility trial, a table of random numbers was used to pre-determine the random order of 
assignment to either the standard dental care plus the mHealth app (SDC+) condition or the 
standard dental care only (SDC) condition. SDC participants were provided information and 
access to the mHealth app after completion of all study procedures.  
Participants were all provided dental treatment with no limitations on the type of 
intervention or the length of time between clinic visits. If the participant canceled their follow-up 
visit, typically scheduled two to eight weeks following the initial clinic visit, they were contacted 
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by study personnel and attempts were made to schedule a return to clinic appointment for study 
procedures.  
During the initial clinic visit, participants were asked to complete the demographic form, 
VAS, RR, PSS, CPGS, PHQ-4, PSQI, and LSI. Next, participants were connected to equipment 
to record physiological measures of BPM, HR, HRV, and ETCO2 during the BL, PRAC, and CT 
sessions.  
Tracking sheets were provided for all participants to record their daily pain levels and 
relaxation ratings. Pain was tracked with a 100mm long VAS and relaxation ratings were 
measured with a 100-point numerical rating scale. SDC participants recorded pain levels and 
relaxation ratings in the morning and evening. SDC+ participants were asked to practice with the 
mHealth app teaching diaphragmatic breathing once in the morning and once in the evening. For 
a detailed description of the entrainment approach used in the SDC+ condition, please see cited 
references (Russell et al., 2014; Russell et al., 2016). To measure the immediate treatment effects, 
SDC+ participants were asked to record pain and relaxation ratings before and after each morning 
and evening practice. All participants were provided instructions on completing weekly 
psychosocial assessments. Every Friday, participants received an email link to an online survey to 
track their perceived stress, chronic pain severity, symptoms of depression and anxiety, sleep 
quality, and exercise engagement.  
All participants were provided a $50 gift card. Participants were made aware of a lottery 
system where participants could earn entries into a lottery drawing for additional $50 gift cards 
through adherence to the study protocol. All participants earned a lottery entry if they completed 
five of the seven daily pain and relaxation ratings during a week or completed the weekly 
psychosocial questionnaires within 48 hours. SDC+ participants could earn an additional lottery 
entry if they practiced with the mHealth app on at least six days during the week.  
SDC+ participants were provided additional information regarding the use of the 
mHealth app including: orientation to an iPod touch, a brief rationale for how the intervention 
38 
 
improves pain management, and a practice outline. Within the outline, participants were asked to 
titrate practice length upwards over the course of their participation. Practice length started at five 
minutes and participants were asked to add one minute each day until practice length was 20 
minutes. Participants were encouraged to practice twice per day. Participants were informed the 
application would track the frequency of use and the duration of each practice. All SDC+ 
participants were provided an iPod touch with the mHealth app installed and an iPod touch 
charger.  
At the second clinic visit, all distributed study materials were collected (tracking sheets 
and iPods). A second five-minute resting physiological measurement of heart rate, average 
breathing rate, and end tidal CO2 levels was taken. Heart rate data was again used to calculate 
HRV incises. Medication changes were recorded and all participants completed the LOPES 
questionnaire to assess for recent significant life stressors. SDC+ participants were asked to 
complete the Participant Self-Report on Efficacy and Tolerability of the mHealth App 
questionnaire. Participants within the SDC condition were offered access to the intervention. 
Participants were provided financial compensation and debriefed. 
Hypotheses  
The study tested whether SDC+ participants experienced significant reductions in their 
breathing rates and improvement in measures of PNS tone above SDC participants. The first 
hypothesis predicted SDC+ participants would show reduced resting breathing rates compared to 
SDC participants. Second, we anticipated SDC+ participants would show greater improvement in 
indices of HRV, increased diaphragm muscle engagement, and improved ETCO2 as compared to 
SDC participants. Our third hypothesis predicted SDC+ participants would show greater 
reductions in VAS and increases in RR than SDC participants. The fourth hypothesis predicted 
SDC+ participants would experience greater improvements on the PSS, CPGS, PHQ-4, PSQI, 
and LSI.  
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HRV Cleaning and Interpretation 
ECG data were visually examined in 60-second tachograms without stage identifiers to 
avoid experimenter bias during cleaning. Missing or erroneous heartbeats were cleaned according 
to the recommendations made by the Task Force and then expanded by the 1997 Committee 
Report (Berntson et al., 1997, p. 631; Task Force,1996). Specifically, movement or aberrant 
heartbeats were visually examined and adjusted for by either measuring the actual R-R interval or 
interpolating the missing heartbeat. Movement artifacts where the heartbeats were not clearly 
indicated were corrected with a mid-beat replacement. Double-marked R peaks and erroneous R 
peaks were removed. Based on recommendation from Mindware Technologies, epochs with over 
10% erroneous beats or that did not have at least 30 consecutive seconds of measurable data were 
not included in calculations. After visual inspection, no participant had more than one 60-second 
epoch excluded and no participants’ physiological recording was excluded from analyses. No 
HRV data were excluded. 
All physiological measures were recorded on a minute-by-minute basis over the course of 
five-minute recordings. Overall means were calculated for each variable over both the baseline 
and second visit physiological recording periods. No measures were excluded.  
Planned Statistical Analyses  
All analyses were conducted using IBM SPSS Version 24. As no inferential statistics 
were used and data were examined from an exploratory perspective, missing data were not 
corrected. Baseline differences between conditions were not explored given the focus on within-
subject changes. However, participant demographic information for the nine drop out 
participants, the eight SDC+ participants, and the two SDC participants are presented separately 
in Table 5.1. Bivariate correlations were performed to explore associations between main 
demographic variables and primary outcome measures at baseline. Bivariate correlation are 
presented for all 19 recruited participants and for the 10 participants who completed a second 
OFPC clinic visit (Table 5.2). 
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To examine Hypotheses 1 and 2 change scores were calculated within each participant 
for each physiological variable. Results are presented in Figures 6.1-6.5. Change scores and 
within participant linear regression models were used to examine Hypothesis 3. Overall change 
scores for VAS and RR were calculated by subtracting the participant’s baseline ratings from the 
participant’s final ratings (Figure 6.6 and Figure 6.8). Treatment changes scores for the SDC+ 
condition were calculated by subtracting the participant’s post-practice ratings from the 
participant’s pre-practice ratings (Figure 6.7 and Figure 6.9). Regression models tested the 
relationships between time (days in study or minutes practicing with App) and daily self-report 
measures (VAS or RR). Findings are discussed and results for each model are presented 
graphically (Figures 6.10-6.13). Differences between the participant’s scores on questionnaires 
over time are also presented graphically with findings discussed (Figures 6.14-6.18). 
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Table 5.1 
 
Participant Characteristics in Study Two 
 
 Dropout Participants  SDC+ Participants  SDC Participants 
Variable M (SD) %  M (SD) %  M (SD) % 
Age  39.67 
(11.66)  
 34.75 
(12.20)  
 32.00 
(1.73)  
Gender          
   Female  66.7   87.5   100.0 
Ethnicity         
   Caucasian or White  88.9   87.5   100.0 
   African American  -   -   - 
   Hispanic or Latino  -   -   - 
   Asian American  -   -   - 
   Other  11.1   12.5   - 
Relationship Status          
   Married  88.9   75.0   100.0 
   Single   -   25.0   - 
   Divorced  11.1   -   - 
Employment Status          
   Employed  88.9   100.0   100.0 
   Unemployed  11.1   -   - 
Blood Pressure         
   Systolic 125.33 
(8.50)  
 116.80 
(10.08)  
 112.33 
(10.21)  
   Diastolic 80.50 
(6.12)  
 75.60 
(5.50)  
 74.67 
(9.02)  
Baseline VAS 59.11 
(15.28)  
 53.13 
(22.51)  
 53.33 
(5.77)  
Days in Study 
-  
 33.13 
(16.55)  
 83.67 
(45.61)  
Secondary Diagnoses         
   Capsulitis  22.2   37.5   - 
Headache attributed 
to TMD  11.1 
 
 25.0 
 
 - 
   Arthralgia  22.2   12.5   50.0 
   Other  22.2   12.5   - 
   Migraine  -   12.5   - 
Degenerative Joint      
Disease  11.1 
 
 - 
 
 50.0 
   TMJ Disc Disorders  11.1   -   - 
Note: Dropout Participants n = 9 (SDC+ = 4 and SDC = 5); SDC+ n = 8; SDC n = 2. VAS = 
Visual Analog Scale for Pain (Gracely, 1983); TMD = Temporomandibular disorders; TMJ = 
Temporomandibular joint. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note: Correlations below the diagonal represent the 10 participants who returned for a second OFPC visit, Correlations above the 
diagonal represent all 19 recruited participants. Condition was recorded as SDC+ = 1 and SDC = 0; Sex was recorded as Female = 0 and 
Male = 1; VAS = Visual Analog Scale of Pain (Gracely, 1983); RR = Relaxation Rating Scale; BPM = breaths-per-minute; HR = heart 
rate; HF-HRV = high frequency heart rate variability (.15 to .4Hz); RMSSD = square root of the mean squared differences of successive 
NN intervals; SDNN = Standard deviation of NN intervals; PSS = Perceived Stress Scale; CPGS = Graded Pain Grade Scale; PHQ-4 = 
Patient Health Questionnaire Four Items; PSQI = Pittsburg Sleep Quality Index (PSQI).  
*p < .05, two-tailed. **p < .01, two-tailed.  
Table 5.2 
Bivariate Correlations among Baseline Measures 
Variable 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 
1.Condition - .14 - .08 .09 - .12 .30 - .32 - .37 - .36 .50* .18 - .40 - .22 
2. Age .13 - .17 .08 - .07 .58* - .45 - .36 - .33 - .28 - .05 - .23 - .16 
3. Sex .17 .39 - .15 - .08 - .45 - .04 - .02 - .05 - .17 .14 .22 - .64** 
4. VAS .07 .15 -.31 - - .18 .13 .03 - .03 - .02 - .47* .25 - .27 - .32 
5. BPM -.37 -.27 .22 -.37 - .08 - .14 .29 .21 - .48 - .05 - .26 .08 
6. HR .00 -.81** -.48 .12 .51 - - .18 - .19 - .20 - .14 - .03 - .37 .19 
7. HF-HRV .12 -.13 .14 .15 -.30 -.21 - .80** .79** - .15 .07 .50* .06 
8. RMSSD -.08 -.00 .01 .05 .33 -.20 .57 - .90** - .25 - .01 .24 - .08 
9. SDNN .35 .18 .43 .13 -.14 -.35 .85** .68* - - .23 .01 .19 - .25 
10. PSS .34 -.12 .20 -.78** -.09 .12 -.27 -.44 -.22 - - .09 .10 - .21 
11. CPGS .31 .36 .21 -.12 -.05 -.68 .15 .15 .18 -.05 - .09 .08 
12. PHQ-4 -.03 -.15 .21 -.58 .01 -.34 .45 .16 .25 .33 .46 - .12 
13. PSQI -.62 -.50 -.48 -.25 .37 .13 .14 .32 -.22 -.19 .06 .50 - 
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Chapter Six: Study Two Results 
Participant Demographics  
The initial study sample consisted of 19 participants. The first four participants recruited 
were all assigned to the SDC+ condition to serve as a feasibility trial. Of the four participants, 
three participants returned for their second OFPC visit and are identified as participants 101, 102, 
and 103. The next 15 participants were randomly assigned to either the SDC+ or SDC condition. 
Of the 15 participants, three SDC+ and five SDC participants dropped out of the study. Of the 
nine total participant dropouts, four participants reported no intentions of returning to the OFPC 
for dental treatment and were unwilling to return for study procedures, and three participants 
discontinued due to time constraints. Following multiple attempts, two participants were 
discontinued due to no contact.  
A total of 10 participants returned to the OFPC for a second visit and were included in 
analyses. Of these 10 participants, eight were in the SDC+ condition (Participants 101, 102, 103, 
1, 3, 7, 10, and 13) and two were in the SDC condition (Participants 2 and 8). Demographic and 
baseline characteristics are presented separately for the nine participants who dropped out and the 
10 participants who were included in analyses (see Table 5.1). No major demographic differences 
were found between the eight SDC+ and the two SDC participants (Table 5.1). Of note, despite 
efforts to restrict the length between visits to no more than eight weeks, the SDC participants 
averaged almost 12 weeks between visits whereas the SDC+ participants averaged slightly under 
five weeks.  
Dental Treatments and Baseline Characteristics  
For all 10 participants, dental treatment included patient education on clenching 
awareness, habit reversal, soft diet, gentle stretches, sleep hygiene, and encouragement to 
function within pain free limits. Six participants were provided stabilization splint therapy 
(Participants: 101, 1, 2, 3, 7, and 13). Three participants were prescribed non-steroidal anti-
inflammatory medications such as Piroxicam, Meloxicam, or clock regulated Ibuprofen 
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(Participants: 2, 3, and 10). Two participants were referred for a sleep study to rule-out sleep 
apnea (Participants 7 and 8). Participant 3 was provided melatonin for difficulties with sleep 
onset. Participant 10 was prescribed a muscle relaxant. No major medication changes were 
reported at the second OFPC visit. In addition, no significant differences between conditions were 
found on the number of life stressors experienced during participation.  
Bivariate correlations were performed to explore baseline associations between variables 
for all 19 recruited participants and the 10 participants who completed study procedures (Table 
5.2). Consistent with previous literature, correlations indicated the HRV measures were highly 
correlated with each other (Berntson et al., 1997; Malik, 1996). Participants’ baseline resting 
heart rate was found to be negatively correlated to participants’ age. Surprisingly, correlations 
indicated a strong negative relationship between VAS pain ratings and PSS scores. Given the low 
sample size, it is possible the finding is a spurious correlation.  
Effect of Intervention on Physiological Variables 
To examine the intervention’s ability to reduce breathing rates above normal dental 
treatment, individual BPM change scores were calculated (Figure 6.1). Five of the eight SDC+ 
participants showed reductions in breathing rates from baseline to their second visit, while both 
SDC participants showed elevated breathing rates. From baseline to the second OFPC visit, only 
two of the eight SDC+ participants experienced an improvement across all three indices of HRV 
(See Figures 6.2-6.4). However, except for Participant 8’s RMSSD change score, both SDC 
participants experienced increases across all HRV indices. Six of the eight SDC+ participants 
showed minimal to moderate increases in ratios of diaphragm engagement over thoracic 
engagement (Table 5.2). Results indicated participants’ end tidal CO2 (ETCO2) were within the 
normal healthy range (35mmHG to 45mmHG) at baseline for both the SDC+ condition (M = 
38.90, SD = 3.22) and the SDC condition (M = 38.67, SD = 3.77). We anticipated participants in 
the SDC+ condition would experience a greater improvement in ETCO2 following exposure to 
the mHealth app than participants in the SDC condition. Yet, results indicated limited changes 
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from baseline to the second visit in ETCO2 for both the SDC+ condition (M = 38.83, SD = 2.87) 
and the SDC condition (M = 38.67, SD = 4.90). The lack of observed change may be a result of 
both conditions starting within a healthy range for ETCO2, thereby, limiting the ability to measure 
a clinical effect.  
Effect of Intervention on General Health Symptoms  
 Results indicated consist reductions in VAS from initial to final ratings as well as before 
and after breathing practices ratings for all SDC+ participants (Figures 6.7 and 6.8). Results also 
suggested improved self-reported ratings of relaxation from initial RR ratings to final RR ratings 
as well as before and after breathing practice RR ratings for SDC+ participants (Figures 6.9 and 
6.10). When examining initial to final ratings for the SDC condition, only half of participants 
experienced a reduction in VAS and an increase in RR ratings. For a more detailed examination 
of VAS and RR changes, four linear regression models using time (days in study and minutes of 
practice with the mHealth app) and daily self-report measures (VAS and RR) were tested within 
each participant. Intercepts and slopes for each model are presented in Figures 6.10-6.13. 
Unfortunately, regression models failed to present a clear picture of treatment effects in VAS or 
RR ratings. In particular, VAS ratings across days in study showed a negative slope in only three 
out of six SDC+ participants (Figure 6.10). In addition, only three out of five SDC+ participants 
showed reductions in VAS across minutes of practice with the mHealth app (Figure 6.11). For 
RR ratings, four out of six SDC+ participants showed increased RR ratings across days in the 
study, while all but one participant showed limited changes in RR across minutes of practice with 
the mHealth app (Figure 6.12 and 6.13).  
In order to examine changes in weekly questionnaires, total scores were calculated and 
are presented graphically for each week in Figures 6.14-6.18. Figure 6.14 indicated participants 
experienced a significant degree of fluctuation in perceived situational stress without consistent 
improvements over the course of treatment. Following treatment onset, outside of Participants 1 
and 3, all participants experienced declines and generally low CPGS scores (Figure 6.15). Again, 
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outside of Participants 1 and 3, all participants indicated minimal levels of psychological distress 
(Figure 6.16). Figure 6.17 suggests moderate levels of sleep disturbances across conditions that 
did not significantly change over the course of treatment. Participants’ physical activity levels 
were also assessed and results indicated wide within- and between-subject variations in the 
amount of physical activity over each week (Figure 6.18).  
Treatment Adherence, Perceived Efficacy, and Tolerability  
SDC+ participants’ adherence to the treatment protocol was assessed through automatic 
tracking of frequency of use and minutes of use within the mHealth app. Given the wide range in 
participants’ length in the study, frequency of use was examined as the number of days with at 
least one mHealth app practice over the total number of days in the study. SDC+ participants’ 
frequency of use ranged from as low as 24% up to 100%. Participants’ total length of practice 
within each week were also calculated as a measure of treatment adherence and are presented in 
Figure 6.19. Result indicated no participants met practice guidelines. Participant 1 was found to 
be the most treatment-adherent. Of note, Participant 1 experienced positive results on the majority 
of outcome variables including: BPM, diaphragm engagement, VAS change scores, and RR 
change scores.  
Examination of frequency of length of mHealth practices highlighted a tendency for 
participants to decrease or discontinue their practice with the mHealth app a week or more before 
returning to the OFPC to complete the final physiological assessment. It is possible the lack of 
practice with the mHealth app leading up to the second OFPC visit limited the study’s ability to 
capture the mHealth app’s effects on outcome measures. On average, the eight SDC+ participants 
had 10.33 days between their last mHealth app practice and their second OFPC visit with a range 
of 0 to 29 days.  
On self-report measures, SDC+ participants reported that they found the mHealth app 
was effective in teaching diaphragmatic breathing (M = 86.13), providing clear directions on 
mechanics of breathing (M = 90.8), and providing clear directions on how to pace their breathing 
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(M = 89.13). SDC+ participants also reported the mHealth app was relaxing (M = 85.13) and 
noted being comfortable in recommending the app to their friends for pain management (M = 
85.25). The majority of SDC+ participants (six) reported they were able to use the app on a daily 
basis. The majority of SDC+ participants also noted “finding time,” “finding alone and quiet 
time,” “time constraints” or “remembering to practice when busy” as the major reasons for not 
meeting the practice frequency or practice length guidelines. When asked to provide feedback on 
the most helpful aspect of the mHealth app, SDC+ participants reported the oval and bells that 
provided visual and auditory pacing aides for the breathing practices as the most helpful aspects. 
Participants indicated “less surveys at first” and “relaxing music in the background” as the two 
changes they would like to see in future iterations of the mHealth app.  
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Figure 6.1. Breaths-per-minute change scores. Blue, solid bars indicate SDC+ 
participants; Orange, striped bars indicate SDC participants. Change scores were based 
on baseline measurement minus final measurement. Higher values indicate a reduction in 
BPM from baseline to final measurement. 
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Figure 6.2. High frequency heart rate variability change scores. Blue, solid bars indicate 
SDC+ participants; Orange, striped bars indicate SDC participants. HF-HRV = High 
frequency heart rate variability (.15 to .4Hz). Change scores were based on baseline 
measurement minus final measurement. Higher values indicate HF-HRV decreased from 
baseline to final measurement.  
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Figure 6.3. Square root of the mean squared differences change scores. Blue, solid bars 
indicate SDC+ participants; Orange, striped bars indicate SDC participants. RMSSD = 
square root of the mean squared differences of successive NN intervals. Change scores 
were based on baseline measurement minus final measurement. Higher values indicate 
RMSSD decreased from baseline to final measurement.  
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Figure 6.4. Standard deviation of NN intervals change scores. Blue, solid bars indicate 
SDC+ participants; Orange, striped bars indicate SDC participants. SDNN = Standard 
deviation of NN intervals. Change scores were based on baseline measurement minus 
final measurement. Higher values indicate SDNN decreased from baseline to final 
measurement.  
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Figure 6.5. Diaphragm over thoracic engagement change scores. Blue, solid bars indicate 
SDC+ participants; Orange, striped bars indicate SDC participants. Change scores were 
based on baseline measurement minus final measurement. Higher values indicate ratio 
decreased from baseline to final measurement. Missing data from Participant 2. 
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Figure 6.6. Overall change in visual analog scale for pain. Blue, solid bars indicate SDC+  
participants; Orange, striped bars indicate SDC participants. VAS = Visual analog scale 
for pain (Gracely, 1983), scores, ranged from 0 (no pain) to 100 (worse pain imaginable). 
Change scores were based on baseline measurement minus final measurement. Higher 
values indicate VAS decreased from baseline to final measurement.  
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Figure 6.7. Treatment change in Visual Analog Scale for Pain for SDC+ participants. 
VAS = Visual Analog Scale for Pain (Gracely, 1983), scores, ranged from 0 (no pain) to 
100 (worse pain imaginable). Change scores were based on pre-practice measurement 
minus post-practice measurement. Higher values indicate VAS decreased from before 
using the mHealth app to after using the mHealth app. Missing data from Participant 7. 
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Figure 6.8. Overall change in Relaxation Rating Scale scores. Blue, solid bars indicate 
SDC+ participants; Orange, striped bars indicate SDC participants. RR = Relaxation 
Ratings Scale, scores, ranged from 0 (not relaxed) to 100 (very relaxed). Change scores 
were based on baseline measurement minus final measurement. Higher values indicate 
RR decreased from baseline to final measurement. Missing data from Participants 7 and 
13.  
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Figure 6.9. Treatment change in Relaxation Ratings Scale scores for SDC+ participants. 
RR = Relaxation Ratings Scale, scores ranged from 0 (not relaxed) to 100 (very relaxed). 
Change scores were based on pre-practice measurement minus post-practice 
measurement. Higher values indicate RR decreased from before using the mHealth app to 
after using the mHealth app. Missing data from Participant 7. 
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Figure 6.10. Change in Visual Analog Scale for Pain across time. Solid lines indicate participants 
in the SDC+ condition; Dotted lines indicate participants in the SDC condition. VAS = Visual 
Analog Scale for Pain, scores, ranged from 0 (no pain) to 100 (worse pain imaginable). Missing 
data from Participants 1, 2, and 7.  
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Figure 6.11. Estimated change in Visual Analog Scale for pain scores with mHealth app practice 
for SDC+ participants. VAS = Visual Analog Scale for Pain (Gracely, 1983) scores ranged from 
0 (no pain) to 100 (worse pain imaginable). Missing data from Participants 103, 1, and 7.  
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Figure 6.12. Change in Relaxation Ratings Scale scores across time. Solid lines indicate 
participants in the SDC+ condition; Dotted lines indicate participants in the SDC condition. RR = 
Relaxation Ratings Scale, scores ranged from 0 (not relaxed) to 100 (very relaxed). Missing data 
from Participants 1, 2, and 7.  
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Figure 6.13. Estimated change in Relaxation Ratings Scale scores with mHealth app practice for 
SDC+ participants. RR = Relaxation Ratings Scale, scores ranged from 0 (not relaxed) to 100 
(very relaxed). Missing data from Participants 103, 1, and 7.   
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Figure 6.14. Change in perceived stress scale scores across time. Solid lines indicate participants 
in the SDC+ condition; Dotted lines indicate participants in the SDC condition. PSS = Perceived 
Stress Scale (Cohen et al., 1983). Scores ranged from 0 (no perceived stress) to 40 (high 
perceived stress).  
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Figure 6.15. Change in Chronic Pain Grade Scale scores across time. Solid lines indicate 
participants in the SDC+ condition; Dotted lines indicate participants in the SDC condition. 
CPGS = Chronic Pain Grade Scale (Von Korff, Ormel, Keefe, & Dworkin, 1992). Scores range 
from 0 (no TMD pain) to 4 (high disability-severely limiting pain). Participants 101, 102, and 103 
had only one data point and are not represented.  
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Figure 6.16. Change in Patient Health Questionnaire 4 scores across time. Solid lines indicate 
participants in the SDC+ condition; Dotted lines indicate participants in the SDC condition. PHQ-
4 = Patient Health Questionnaire 4 (Kroenke et al., 2009). Scores range from 0 (normal) to 12 
(severe symptoms of depression and anxiety). Participants 101, 102, and 103 had only one data 
point and are not represented.   
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Figure 6.17. Change in Pittsburg Sleep Quality Index total scores across time. Solid lines indicate 
participants in the SDC+ condition; Dotted lines indicate participants in the SDC condition. PSQI 
Total = Pittsburg Sleep Quality Index total (Buysse, Rynolds III, Monk, Berman, & Kupfer, 
1989). Scores ranged from 0 (better sleep) to 21 (worse sleep). Participants 101, 102, and 103 had 
only one data point and are not represented; Participant 3 was missing data from weeks 0-1.  
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Figure 6.18. Change in Godin Leisure-Time Exercise Questionnaire total scores across time. 
Solid lines indicate participants in the SDC+ condition; Dotted lines indicate participants in the 
SDC condition. LSI = Godin Leisure-Time Exercise Questionnaire (Godin & Shephard, 1985). 
Scores begin at 0 (no exercise) with higher scores indicating more physical activity over the past 
week. Missing data from participants 101, 102, and 103; Participant 10 had only one data point 
and is not represented.  
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Figure 6.19. SDC+ participants’ total practice time in minutes over each week in the study. 
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Chapter Seven: Study Two Discussion 
 The focus of Study Two was to explore the feasibility, tolerability, necessary treatment 
dosage, and clinical efficacy of a mHealth based conjunctive treatment for persistent TMDs with 
a primary diagnosis of chronic myofascial pain. The current results represent a small sample size 
not investigated with inferential statistics, but aimed to guide future clinical trials using mHealth 
based behavioral interventions within this population. The discussion, therefore, will focus on 
identifying general themes, presenting potential conclusions, and providing considerations for 
future research directions.  
Interpretation of Results 
Consistent with hypotheses, the mHealth app reduced breathing rates and produced 
moderate effects in improving diaphragm over thoracic engagement during respiration. The 
majority of participants (i.e. 101, 102, 103, 1, and 7) who showed the most improvement in 
diaphragm engagement and reductions in BPM also experienced the largest reductions in VAS 
measures. Of note, Participant 1, who was the most SDC+ treatment-adherent, experienced the 
greatest relief in pain, increase in relaxation from pre- and post-mHealth app practices, and the 
fourth highest overall reduction in VAS pain ratings. Despite most participants experiencing a 
reduction in BPM and an increase in diaphragm engagement, results did not uniformly support 
the mHealth app’s ability to increase HRV indices. In addition, little change was observed in 
ETCO2. As participants’ baseline ETCO2 recordings were within the healthy range of 35 to 
45mmHG, results were consistent with the initial hypothesis. The mHealth app demonstrated the 
ability to teach deep diaphragmatic breathing while avoiding over-breathing identified through 
ETCO2 recordings below 35mmHG. Overall, the mHealth app appears to have assisted in the 
reduction of pain, but the added efficacy of the combined use of the mHealth app with standard 
dental care remains unclear.  
Inability to produce consistent effects on HRV indices are potentially explained by 
several factors. First, for many SDC+ participants several days (M = 10.33 days) between their 
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last use of the mHealth app and their second OFPC visit may have served as a wash out period. 
The long-term effects of breathing based interventions on baseline levels of HRV remain unclear. 
It, therefore, seems important for participants to continue their use of the mHealth app through 
their second physiological recording in order to assess the intervention’s efficacy. An additional 
consideration is the temporal stability of HRV. Although HRV is thought to remain stable under 
stable conditions over time, HRV is capable of fluctuating during measurement due to body 
position, mental stresses, recent physical exertion or consistent exercise habits, controlled 
respiration, cold stimulation to the face, certain medications (e.g. beta-adrenergic or 
antiarrhythmic medications), or fluctuations in hormone levels (Berntson et al., 1997; Malik, 
1996). Although research guidelines were consulted to avoid the influences of these factors, the 
effects on HRV indices were complicated by the use of controlled breathing, the prediction of 
changes in mental and physical stress through reduction of pain, and the wide variability in time 
between participants’ first and second physiological recordings. Given the challenges of requiring 
participants to return for multiple in-person physiological recordings, future research should 
consider the use of more frequent HRV assessments through validated smart phone technologies.  
During breathing at rest, results suggested the mHealth app was successful at increasing 
participant’s engagement of the diaphragm muscle. As six of the eight SDC+ participants 
experienced an increase in the ratio of diaphragm over thoracic muscle engagement, it can be 
concluded the mHealth app was successful in teaching diaphragmatic breathing mechanics. It is 
important to note participants’ ETCO2 recordings remained within a healthy range, which 
indicated the mHealth app was able to successfully teach diaphragmatic breathing without 
causing hyperventilation (i.e. deep breathing at too fast a pace).  
Through treatment, all participants in the study except one SDC participant experienced 
an overall reduction in VAS pain ratings. Seven SDC+ participants found the mHealth app 
resulted in an increased state of relaxation following each breathing practice. Of note, the one 
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participant who failed to experience an increase in relaxation had an increase in BPM over the 
course of their participation.  
Data suggested a strong clinical effect of the mHealth app on VAS and RR ratings 
immediately following practice. Results supported the use of the mHealth app for temporary 
relief of pain and increased relaxation but did not support a sustained effect on HRV indices. The 
lack of consistent effects may have resulted from limited treatment adherence within the SDC+ 
condition and variable treatment length. SDC+ participants practiced with the mHealth app for 
almost half as long as was suggested for each day (40 minutes) to reach a clinical effect (M = 23.8 
minutes, SD = 9.71). Although a portion of this is due to the upward titration program that started 
SDC+ participants at five minutes of health practice, examination of participant practice logs 
reveled frequent days where participants failed to use the mHealth app even once (an average of 
43% of the days in the study).  
Results failed to show consistent improvements for SDC+ participants in general health 
outcomes such as perceived stress, psychological distress, or sleep. Failure to support our 
hypotheses may have resulted from participants’ missing data, variable lengths in treatment, poor 
treatment adherence, or the small sample size. Given the difficulties with participant recruitment 
and retention, future research would benefit from using a one session intervention to test the 
clinical effect for patients with persistent TMDs on VAS and RR ratings. Future work should 
focus on delivery of questionnaires in a manner that facilitates greater treatment engagement such 
as providing links to the questionnaires within the mHealth app.  
After the mHealth app has proven clinical efficacy, research can shift to testing the 
effects of prolonged exposure to the mHealth app and the necessary dosage to produce a 
persistent clinical effect on pain. There is also a need to investigate methods to improve 
participant adherence to treatment and the role of the clinician versus the mHealth app in teaching 
behavioral self-regulation skills. Results did indicate the mHealth app was tolerated well by 
SDC+ participants and did not precipitate any negative outcomes. Yet, it is important to consider 
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how to improve the current project in future examinations of mHealth apps within clinical 
populations.  
Lessons in Feasibility 
 A major obstacle of the study was participant recruitment and attrition. Although the 
OFPC sees over 30 new patients a month, the present project’s recruitment was limited by the 
specific inclusion criteria used to create a homogeneous sample. Given the goal of recruiting 
treatment seeking patients, no outside advertisement was used. The benefits of recruiting 
community participants who meet inclusion criteria but are not actively seeking treatment for 
persistent TMDs should be considered. Concerns with sample size were compounded by a 47% 
dropout rate. Drop out participants reported no intentions of returning for further treatment at the 
OFPC and time constraints as the primary reasons for discontinuing their participation in the 
project. As most participants were not local residents, it is likely that travel time and the cost of 
their ongoing treatment at the OFPC played a significant role in discontinuing treatment. When 
compared to participants who completed the protocol, drop out participants were found to be 
slightly older than SDC+ participants (M = 4.92 years) and SDC participants (M = 7.67 years). 
Drop out participants also had slightly higher baseline VAS from SDC+ participants (M= 5.98) 
and SDC participants (M = 5.78). As the present study required considerable time commitment 
from participants, we believe participant retention would be helped with future protocols being no 
longer than two to three weeks. If possible, collaboration with the participant’s local dental 
providers should also be sought to limit participant travel burden. Lastly, the effects of providing 
a variety of dental procedures for study participants should be explored.  
 An additional consideration for future work is adjusting the titration schedule with the 
mHealth app. SDC+ participants were asked to begin at five minutes for each practice and add 
one minute each day. As participants generally failed to adhere to the titration schedule, the 
benefits for treatment adherence of beginning mHealth app practices at various lengths is of 
interest. Examination of participants’ use of the mHealth app indicated use noticeably declined 
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following week two and participants who were not initially using the mHealth app were unlikely 
to begin use later in their time of participation. The use of regular reminder notifications through 
the app and phone check-ins for improved adherence should also be explored.  
 Finally, the approach to recruiting and the rationale provided to new participants needs 
further consideration. The purposeful inclusion of motivational interviewing techniques during 
recruitment to facilitate participant engagement represents an area of future improvement. 
Another consideration is the added confidence in the efficacy of the mHealth app that would be 
achieved through a single in-person training session with personalized clinician feedback. 
Overall, the results suggest future exploration of mHealth app use with individuals suffering 
persistent TMDs is warranted.  
Future Directions  
 Results from the current study indicate further research is needed to examine the potential 
benefits of including mHealth interventions that target autonomic dysregulation. The continued 
exploration of mHealth apps with individuals suffering persistent pain conditions is paramount 
given the burden of care currently placed on providers and the stressors on patients associated 
with frequent clinic visits. Although the present study outcomes did not support the positive 
effects of the mHealth app on indices of HRV, previous literature has demonstrated the ability of 
technology assisted protocols to produce meaningful changes in HRV indices (Russell et al., 
2014; Russell et al., 2017). It is important to note the positive effects of the intervention on self-
reported levels of pain over the course of the study and immediately following each use of the 
mHealth app. Thus, it would be valuable to pursue the study of a breathing app to improve 
symptom management with several key refinements to the research protocol. 
 First, the high participant dropout rate limited results and raised significant concerns 
regarding participant retention and engagement in mHealth app conjunctive treatments. Future 
research on strategies to limit participant dropout are important and examination of dropout 
participants’ perceptions towards mHealth app based conjunctive treatments should be explored. 
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Based on participant qualitative feedback, the present study would have benefited from limiting 
the length of participation to two weeks. There were significant time commitments required to 
adhere to the study protocol, which likely impacted participant treatment adherence and 
participant retention. In addition, the costs associated with receiving dental care during the study 
must be managed and followed more carefully.  
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Chapter Eight: Overall Discussion  
Study One 
 Study One supported the use of a CBT based protocol teaching slow paced diaphragmatic 
breathing to influence respiration rates and HRV indices. The DB condition showed lower 
breathing rates and significantly higher improvements on both HF-HRV and SDNN than the MB 
or C conditions. No significant differences were found between conditions for the behavioral self-
regulation task suggesting the effects of the breathing interventions were limited in duration or 
strength. The training period for each condition was brief by design (~six minutes) with only five 
minutes for participants to practice the new skill before being exposed to the behavioral self-
regulation task. The brief nature of the intervention likely limited the long-term effects on 
participants’ behavioral self-regulation. Therefore, it is important to consider practice duration 
before exposure to self-regulatory tasks. In addition, the behavioral self-regulation task suffered 
from a ceiling effect with a sample of relatively healthy young adults. Taken together, results 
suggested the next step was to examine the DB condition training protocol with a population 
suffering persistent TMDs.  
Study Two 
Study Two evaluated the impact of including the DB training protocol delivered through 
a mHealth app with standard dental treatments. Results did not indicate the mHealth app 
significantly improved treatment outcomes overall above participants receiving dental treatment 
alone. However, several findings supported further investigation of the DB protocol as a 
conjunctive treatment for persistent TMDs. First, SDC+ participants reported the mHealth app 
was tolerable and produced a reliable reduction in pain and increase in feelings of relaxation after 
each breathing practice. In addition, despite having only one of eight SDC+ participants reach the 
recommended clinical dose with the mHealth app, all participants experienced a reduction in pain 
over the course of participation. Taken together, results support continued examination of 
mHealth app based interventions teaching paced diaphragmatic breathing.  
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However, several concerns were identified in results that require attention. Consistent 
with previous literature, a primary issue in the present project was treatment adherence (Schmidt 
et al., 2012; Schmidt et al., 2013). As the most treatment-adherent participant experienced the 
greatest average reduction in pain after each breathing practice, it can be theorized improved 
treatment adherence would result in greater reductions in pain. A lack of treatment adherence is a 
likely a factor in the intervention’s limited effects on physiological factors. For instance, only two 
SDC+ participants showed large decreases in BPM over the course of treatment. Respiration rates 
between six to seven BPM are necessary to significantly effect HRV indices (Lehrer et al., 2003; 
Lehrer & Gevirtz, 2014). Although the mHealth app improved engagement of the diaphragm in 
the majority of SDC+ participants, future protocols must be adjusted to reduce participants’ 
respiration rates to the six to seven BPM range. Failure of SDC+ participants to reach this 
threshold is a major concern for future research. In addition, SDC+ participants used the app at 
least once for only 57% of the days they were involved in the study. SDC+ participants averaged 
23.8 minutes of practice per day, which was greatly below the suggested practice length of 40 
minutes per day. With limited treatment adherence, it is not surprising to find little difference in 
overall symptom reduction between SDC+ and SDC participants. Yet, despite the poor overall 
treatment adherence, participants consistently displayed positive effects of treatment on daily pain 
and relaxation ratings. Thus, future research is necessary to determine if an increase in “dose” of 
practice to 40 minutes per day results in improved outcomes on pain and relaxation.  
Limitations 
There are several limitations that need to be acknowledged. Although the DB condition 
generally outperformed the two other training approaches in Study One, the potential impact of 
multiple training sessions needs additional investigation. In addition, despite attempts to limit 
participant dropouts with the use of limited participant burden, financial incentives, and potential 
treatment benefits, Study Two results were severely limited by sample size. Although semi-
flexible lengths in participation were initially viewed as a means to limit the effects of TMD 
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symptom severity following various patterns (i.e. persistent or recurrent) and strengthen 
generalizability to dental practices, it is likely this design led to additional complications in the 
interpretation of outcomes. Participants were involved in treatment for greatly variable lengths of 
time ranging from 14 days to 131 days. Future research should consider standardizing participants 
exposure to the mHealth app and explore the subsequent influence on respiration rates and HRV 
indices within a clinical population.  
A recent a meta-analysis of available randomized clinical trials examined the 
effectiveness of psychosocial and dental treatments for amelioration of persistent TMD 
symptomology (Roldán-Barraza et al., 2014). Although interpretations of data overall were 
hampered by a limited number of studies containing standardized measures, results suggested 
patients experienced greater long-term outcome efficacy following a psychosocial intervention 
compared to standard dental treatment alone. These findings are consistent with recommendations 
of others who have suggested the addition of psychosocial interventions for patients with TMDs 
(Carlson et al., 2001; Gatchel et al., 2007; Roldán-Barraza et al., 2014; Schmidt et al., 2013). 
Further study of psychosocial interventions exploiting mHealth apps into traditional dental 
treatments would be of substantial benefit. 
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